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Abstract 
 
Adipose tissue homeostasis is regulated by a combination of extracellular and 
intracellular signalling pathways. Activation of surface G protein-coupled receptors 
(GPCR) and insulin receptors, influence the rate of lipolysis within adipocytes, the 
pathway responsible for triacylglycerol (TAG) breakdown into non-esterified fatty acids 
(NEFA) and glycerol. A GPCR for short chain fatty acids (SCFA) has been identified 
on the surface of mature adipocytes and activation of this receptor by SCFA including 
acetate, butyrate and propionate has resulted in a decrease in lipolysis, measured as a 
reduction in NEFA and glycerol concentration in the media. However, evidence for a 
mechanism of action of SCFA within adipocytes has remained unclear. Therefore, this 
thesis has aimed to better understand the mechanism(s) by which the SCFA, acetate, 
regulates adipose tissue metabolism and function, and in particular the pathway of 
lipolysis. 
Through the development of experimental methods in vitro, it was determined that the 
dose of isoproterenol, a β-adrenergic receptor activator, required to stimulate lipolysis 
by 50 % in murine 3T3-L1 adipocytes, was 5 µM, and that no interference with 
metabolic assays was observed in the presence of any potential treatment condition, 
either in the basal or stimulated state. In 3T3-L1 cells, in the basal state, treatment of 
cells with the short chain fatty acid acetate (4 mM), significantly reduced lipolysis, as a 
measure of NEFA and glycerol (P = 0.004 and P = 0.020, respectively) after a 180 min 
incubation. Similarly, in the stimulated state, acetate also reduced NEFA significantly 
(P = 0.020), however, glycerol was not reduced (P = 0.529) compared with controls. To 
evaluate whether the metabolic changes in NEFA and glycerol concentration reflected 
an intracellular change to the pathway of lipolysis, phosphorylation of the key enzyme, 
hormone sensitive lipase (HSL), was also analysed. It was identified that in the 
stimulated state, phosphorylation of HSL, at serine residue 563, was reduced by 15 % in 
the presence of 4 mM acetate, compared with control, complimentary to metabolic data. 
However, treatment of isolated primary mouse mature adipocytes with acetate did not 
produce results comparable to those found in the literature. Instead, accumulation of 
NEFA and glycerol in the media were found to be negligible. Cell viability may have 
been a limiting factor regarding the outcome of these studies, and therefore 
development of a protocol to improve cell viability without compromising cell yield 
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would prove useful.  Furthermore, future work should consider the lack of reduction in 
glycerol in the media in the stimulated state from 3T3-L1 mature adipocytes.  This may 
be accounted for by fatty acid re-esterification, as the NEFA:glycerol ratios were 1.5:1, 
compared with the expected 3:1 ratio. Similarly, to re-enforce the effects of acetate on 
stimulated lipolysis, other phosphorylation sites within HSL may be considered, 
including SER565. 
Overall, the results obtained in this thesis demonstrate that in the mature adipocyte cell 
line 3T3-L1, an increase in the availability of the SCFA, acetate, resulted in a change in 
the pathway of lipolysis. This was evidenced by a reduction in the phosphorylation of 
HSL(SER563) under sub-maximal stimulation with isoproterenol, similar to levels 
observed in the presence of insulin.  Complimentary to these data, under the same 
treatment conditions, incubation with acetate also resulted in a small but significant 
reduction in NEFA concentration in the media.   
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Whole body metabolism  
In the Scottish Health Survey 2012 (Scottish-Government, 2013) it was reported that 
over 60 % of men and women living in Scotland were recognised as either overweight 
or obese, with ~ 30 % having a body mass index (BMI) of ≥ 30 kg/m2.  Correlations 
also exist between overweight/obesity and the co-morbidity of cardiovascular disease, 
hypertension and Type II diabetes (Keenan et al., 2011).  Therefore, there is a clear 
social and economic benefit for reducing the rate of overweight/obesity and related 
diseases in the UK and elsewhere.  However, in order to achieve this reduction, there is 
a need to better understand the underlying mechanisms involved in adipose tissue (AT) 
metabolism and function. The lipolytic cascade involved in the breakdown of lipids in 
AT is regulated by both β-adrenergic receptor (β-AR) activation and insulin sensing. 
The converging step, linking both pathways to lipolysis, occurs via the abundance of 
cyclic adenosine monophosphate (cAMP) within adipocytes.  An increase in available 
cAMP can occur through activation of stimulatory G protein-coupled receptors (GαS), 
resulting in an increase in non-esterified fatty acid (NEFA) and glycerol release. 
Conversely, activation of the insulin receptor which is known to reduce cAMP to 
5’AMP via phosphodiesterase 3B (PDE3B), results in a reduction in overall lipolysis .  
Similarly, activation of inhibitory G protein-coupled receptors (Gαi), also reduce the 
availability of cAMP, however, through down regulation of adenylate cyclase.  Proteins 
involved downstream of cAMP sensing within lipolysis, including hormone sensitive 
lipase (HSL), can be studied for changes in phosphorylation, as a marker for 
intracellular lipolysis.  Identification of changes to the phosphorylation of HSL would 
ensure lipolysis is directly affected without discriminating between activation sites, 
including G protein-coupled receptors (GPCR) or insulin receptors.  Further to this, 
measurement of metabolic compounds such as NEFA, glycerol and intracellular 
triacylglycerol (TAG) would also complement  these findings.         
Obesity has been documented as an epidemic found predominately in the developed 
world for over 20 years (WHO, 1990), however, associated diseases, such as Type II 
diabetes have been investigated for over 70 years (Himsworth, 1939).  More recently, 
studies have focused on understanding the mechanism of action relating diet and 
nutrition to metabolic disorders.  Initial links between the regulation of glucose and 
fatty acid utilisation were first published in 1963 by Randle et al. (1963).  In this paper, 
Randle and colleagues (1963) summarised that a cyclical process affected both glucose 
availability/metabolism and free fatty acid production/oxidation and was termed the 
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glucose fatty acid cycle.  The publication included data showing how an increase in 
fatty acid oxidation impacted on glucose phosphorylation, glycogen metabolism, 
glycolysis and pyruvate oxidation in rat and human models, using examples from heart, 
diaphragm muscle and liver, both in vivo and in vitro.  This initial hypothesis in 1963 
has also been verified by others, as Nuutila et al. (1992) published data in which an 
increase in free fatty acid oxidation resulted in a decrease in whole body glucose uptake 
in humans.  An increase in fatty acid oxidation contributed to a decrease in whole body 
glucose uptake as measured by the decrease in glucose uptake in femoral and arm 
muscle tissue.  Also, glucose uptake was found to be decreased in the heart muscle; 
however, this decrease did not contribute significantly to the overall decrease in whole 
body glucose uptake (Nuutila et al., 1992).  The mechanisms involved in this cycle are 
complex; however the importance of the pyruvate dehydrogenase complex (PDH) has 
shed light on these interlinking metabolic pathways.  When activated (de-
phosphorylated), the PDH complex catalyses the oxidative decarboxylation of pyruvate 
to acetyl-CoA, linking glycolysis and energy storage with energy availability and free 
fatty acid oxidation (Holness and Sugden, 2003), as shown in Fig. 1.1.   
 
Fig 1.1 PDH complex adapted from Holness and Sugden (2003). Interaction between long chain 
fatty acid β-oxidation and glycolysis through the PDH complex. PDH, Pyruvate 
Dehydrogenase; NAD
+
, Nicotinamide Adenine Dinucleotide; NADH, Nicotinamide Adenine 
Dinucleotide + Hydrogen; CoA, Co Enzyme A. 
 
Since 1963, further experiments have been conducted to ascertain the molecular basis of 
these interacting pathways, including a complementary mechanism to the glucose fatty-
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acid cycle, reviewed by Frayn (2003).  The mechanism proposed by McGarry et al. 
(1977) inferred inhibition of carnitine acyl transferase 1 (CAT1) by malonyl CoA, 
which occurred due to excess citrate moving out into the cytosol of liver cells.  The test 
involved the long chain fatty acid (LCFA) and the medium chain fatty acid (MCFA), 
oleic and octanoic acids, respectively.  A decrease in the level of LCFA but no change 
in the level of MCFA in the presence of malonyl CoA, allowed for the hypothesis that 
one or more of the LCFA transport proteins must be affected.  As malonyl CoA would 
not be able to make contact with the inner mitochondrial transport machinery, it was 
proposed that CAT1 must be involved in the decrease of fatty acid oxidation in liver 
cells.  The specificity of malonyl CoA to inhibit CAT1 was elucidated using other CoA-
derivatives and intermediates from processes, such as the tricarboxylic acid cycle and 
from glycogen-pyruvate conversions.  No other metabolites were able to produce the 
same level of reversible inhibition as malonyl CoA (McGarry et al., 1977).  Evidence 
for CAT1 involvement in a glucose induced reduction in fatty acid oxidation have also 
been identified in other tissues, including muscle, as reviewed by Zammit (1999).  
These data demonstrate that the glucose fatty acid cycle sustains the homeostatic 
balance of energy availability within the body.  However, weight gain and obesity can 
ensue if increased calorie intake outweighs energy expenditure.  
 
Nutrient availability 
Contributing on average 45 - 65 % of the recommended daily intake of calories, 
carbohydrates account for a large portion of ingested food on a daily basis (NHS, 2010).  
Of this, increases in non-digestible carbohydrates, including dietary fibre, such as 
resistant starch and lactulose (Puupponen-Pimiä et al., 2002), have led to increased 
levels of fermentation in the gut , and an increase in the production of the short chain 
fatty acid (SCFA) acetate as a consequence (Ferchaud-Roucher et al., 2005, Macfarlane 
and Macfarlane, 2003).  Alcohol is also recognised as a source of increased SCFA 
availability following its metabolism in the liver as described by Siler et al. (1999).  
Nilsson and Belfrage (1978) compared ethanol, acetate and acetaldehyde availability in 
isolated rat adipocytes and reported that increased acetate, the metabolised form of 
ethanol, resulted in a decrease in the release of glycerol (measure of lipolysis) by 25 - 
70 %.  However, the decrease in glycerol production was only observed in the presence 
of the β-AR stimulator norepinephrine.  It should also be noted that the concentrations 
of acetate used in this study were supra-physiological (0 – 10 mM), compared with the 
5 
 
concentration of acetate released from the liver, after crossing the gut lumen (17.3±7.3 
mmol kg bodyweight
-1
 h
-1
).  SCFA are typically categorised as having an aliphatic tail 
of less than 6 carbon atoms, the most common of these being acetate (C2), propionate 
(C3) and butyrate (C4).  The presence of increased SCFA availability in humans has 
been linked to diet. Studies carried out before 2000 published data on the production of 
SCFA, their interaction with the gut wall and the effect they had on particular gut 
related diseases.  Whereas over the last 10 years studies have tried to ascertain the fate 
of SCFA after absorption through the large intestine gut wall.  Information available on 
SCFA after crossing the gut lumen barrier was restricted, as procedures to measure 
portal and hepatic vein SCFA levels were invasive.  A recent study by Bloemen et al. 
(2009), and the first reported study of portal blood SCFA concentration by Peters et al. 
(1992) provided a greater insight into where these important fatty acids end up after 
crossing the gut membrane.  It was reported that SCFA could reach the portal vein as 
quickly as 15 minutes after introduction, illustrating the speed of colonic fermentation 
and gut absorption (Peters et al., 1992).  Recent studies have included measurement of 
hepatic SCFA levels which were not previously assessed, and clarified our 
understanding of the fate of SCFA after crossing the gut barrier by describing that 
propionate and butyrate can become potentially toxic in higher levels (Tedelind et al., 
2007, Manns and Boda, 1967) as cited by Bloemen et al. (2009), and are therefore 
rapidly cleared from the circulation and metabolised by the liver.  Propionate, butyrate 
and acetate were metabolized in the liver, however, roughly 70 % of 24 g administered 
ethanol was released as acetate by the liver, into the circulation acting on other tissues, 
including AT and muscle tissue at a concentration of 47.5 ± 2.5 mmol ·kg
-1
 ·min
-1
 (Siler 
et al., 1999).  It was identified that the G protein-coupled receptor GPR43 was specific 
for SCFA (Le Poul et al., 2003), with receptors present in a number of tissues, although 
in this particular study GPR43 was not found in adipose tissue.  However, since 2003, 
the presence of GPR43 in adipose tissue depots including subcutaneous and epididymal 
has been identified.  Other GPCR sensitive to agonist with small carboxylic tails have 
also been found in adipose tissue, including the prostaglandin E2 (PGE2) receptor EP3 
and nicotinic acid receptor HM74A.  The natural ligand for HM74A, however, remains 
elusive, as physiological concentrations of nicotinic acid are unable to induce a 
response. (Jaworski et al., 2009, Zhang et al., 2005). Furthermore, activation of GPR43 
with SCFA have been found to promote both lipogenesis (Hong et al., 2005) and inhibit 
lipolysis (Ge et al., 2008).  These diverse findings surrounding the effect of SCFA on 
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AT metabolism demonstrate a need to better understand the mechanism of action 
involved.  
 
Adipose tissue homeostasis: Intracellular and extracellular signalling 
Adipose tissue metabolism 
Regulation of AT encompasses the intricate balance between breakdown and synthesis 
of triacylglycerol (TAG), for storage, or as an energy source depending on the 
nutritional status of the mammal.  Therefore lipolysis and lipogenesis (Fig. 1.2 and Fig. 
1.3) are tightly controlled by a number of signals including but not limited to second 
messengers, hormones and adipokines (Jaworski et al., 2007).  Literature reviews of 
these pathways, including the interaction between lipolysis and the metabolic syndrome 
(Langin, 2006), as well as a newly discovered protein, central to the control of lipolysis 
(Villena et al., 2004), are continually up-dating our understanding of adipose tissue 
homeostasis. 
 
Intracellular signalling 
Since identifying the existence of adipose triacylglycerol lipase (ATGL/Desnutrin) in 
2004, for the hydrolysis of TAG into diacylglycerol (DAG) (Villena et al., 2004, 
Zimmermann et al., 2004, Jenkins et al., 2004) and a greater understanding of fatty acid 
re-esterification (Jensen et al., 2001), and TAG turnover as reviewed by Reshef et al. 
(2003), it has now been established that AT is much more metabolically active than 
previously reported, and the process of lipid metabolism is more complex.  As AT is the 
main storage site for fat consumed in the diet, the process of lipolysis is responsible for 
mobilising TAG within lipid droplets located within individual adipocytes.  The process 
utilizes three lipases sequentially hydrolysing fatty acids from the TAG backbone.  It 
was originally hypothesized that HSL was responsible for the first two hydrolysis steps, 
however it is now widely accepted that ATGL hydrolyses the first free fatty acid.  This 
lipase was found to be more potent than HSL at hydrolysing TAG into DAG, and unlike 
HSL, which required phosphorylation by PKA to become active, ATGL did not 
(Villena et al., 2004, Zimmermann et al., 2004, Jenkins et al., 2004).  Phosphorylation 
of HSL by protein kinase A (PKA) stimulates pHSL translocation to the lipid droplet 
surface where it hydrolyses DAG into MAG, releasing one free fatty acid (Fig. 1.2), 
finally leaving monoacylglycerol lipase (MAGL) to cleave the final fatty acid from the 
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glycerol backbone (Duncan et al., 2007).  Although the proteins involved in TAG 
hydrolysis have now been identified, the exact mechanism in which TAG is stored in 
lipid droplets, and the method by which lipases access these stores has, however, never 
been fully understood.  
Individual adipocytes store TAG in monolayer lipid droplets, however, the way in 
which these droplets are generated, mature and increase in size still needs further 
investigation (Walter and Farese Jr, 2009).  Several mechanisms for the growth of lipid 
droplets have been proposed, including influx of TAG instead of droplet to droplet 
fusion, and also the involvement of Caveolin-1  (Kuerschner et al., 2008, Cohen et al., 
2004).  
 
 
Fig 1.2  Adapted from Marcinkiewicz et al. (2006), Ahmadian et al. (2009). Pathway of 
lipolysis: Activation of Gαs or Gαi G protein-coupled receptors via β-AR receptors, and the 
subsequent lipolytic pathway. β-AR, Beta Adrenergic Receptor; Gαi, G alpha inhibitory protein; 
Gαs, G alpha stimulatory protein; PGE2, Prostaglandin E2; PKA, Protein Kinase A; HSL, 
Hormone Sensitive Lipase; ATGL, adipose triacylglycerol lipase; TAG, triacylglycerol lipase; 
DAG, diacylglycerol lipase; MAG, monoacylglycerol lipase; FA, fatty acids. 
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Fig 1.3   Pathway of lipogenesis: Insulin receptor signalling and Glut4 translocation from an 
intracellular store followed by triacylglycerol synthesis and lipid droplet formation. Glut4 
Glucose receptor 4, PPARγ Peroxisome proliferator-activated receptor gamma. 
 
It has been shown that Caveolin null perilipin A mouse embryonic fibroblast (peri 
MEF) do not build up the same volume of lipid in their lipid droplets compared to wild 
type mammals to a significant extent.  Perigonadal AT isolated from the Caveolin-1 null 
mice also had a decreased response to lipolytic agonists showing that the decrease in 
lipid volume due to a lack of Caveolin-1 in the lipid droplet membrane also affected 
adipose tissue metabolism (Cohen et al., 2004).  However, the mechanism by which 
lipid droplets are formed in the first place remains elusive. The most common 
assumption is monolayer bulging and budding from the endoplasmic reticulum (ER). 
The presence of lipid droplets within adipocytes has been noted for many years, 
however, their complexity has only come to light over the last decade (Brasaemle, 2007, 
Londos et al., 2005).  The main family of proteins associated to the lipid droplet 
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membrane surface has been identified as the PAT family, consisting of Perilipin, 
Adipophilin, TIP47 and two others, OXPAT and S3-12. Brasaemle et al. (2004) 
identified that perilipin, S3-12 and TIP47 localise to the lipid droplet surface, under 
both basal and stimulated lipolysis in 3T3-L1 cells, whereas adipophilin was selectively 
localized to the lipid droplet of stimulated cells.  It has been hypothesized that perilipin 
surrounds the lipid droplet creating a ‘scaffolding-like’ structure allowing access by 
lipases to the lipid surface only when the perilipin coat is phosphorylated (Brasaemle, 
2007).  One hypothesis proposes, after phosphorylation of the perilipin coat by PKA, 
that the lipid droplet breaks down into smaller mini droplets, increasing the surface area 
of the droplet in contact with the surrounding lipase and therefore allowing the start of 
TAG hydrolysis (Marcinkiewicz et al., 2006) (Fig 1.2).  However, as lipolysis does not 
function unrestrained, in opposition to an increase in lipolysis and subsequent TAG 
hydrolysis, activation of the insulin receptor (IR), results in a reduction in lipolysis. As 
shown by Berggreen et al. (2009), a converging step within the pathway of lipolysis has 
been identified, where insulin receptor activation resulted in activation of PKB, and 
subsequent reduction in glycerol release from rat and 3T3-L1 adipocytes.  Previously, it 
has been shown that PKB mediates the activation of PDE3B, the enzyme responsible 
for converting cAMP to 5’AMP (Kitamura et al., 1999).   
After a meal, blood glucose rises, closely followed by a rise in plasma insulin released 
from pancreatic β-cells.  In adipocytes, the binding of insulin to its receptor, leads to a 
decrease in overall lipolysis and therefore a decrease in NEFA and glycerol release. In 
metabolic disorders, such as Type II diabetes, insulin sensing becomes impaired, 
leading to changes that include hyperglycaemia (Rigalleau et al., 2010) and 
hyperinsulinemia, as reviewed by Shanik et al. (2008).  The signalling pathway 
involving insulin is complex, as evidence for both PKB dependant (Kitamura et al., 
1999) and independent (Choi et al., 2010) regulation of PDE3B have been proposed. 
However, regardless of activation, in both cases, PDE3B has been found to hydrolyse 
cAMP to 5’AMP, decreasing PKA phosphorylation of downstream proteins, such as 
HSL and perilipin.  Therefore, insulin receptor activation and β-adrenergic receptor 
activation work reciprocally to regulate NEFA and glycerol release.  Signals required to 
activate these receptors can initiate from other tissues, and extracellular control of 
adipose tissue has been documented in great detail, including sympathetic nervous 
system (SNS) control of insulin release from pancreatic β-cells (Lustig, 2008), and 
activation and release of catecholamines, as reviewed by Bartness et al. (2010). 
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Extracellular signalling 
For many years, research on the extracellular regulation of adipocyte metabolism has 
focused on hormones and other circulating factors, identified for their effects on energy 
storage and release, including insulin, leptin, adipokines and from the gastrointestinal 
tract (GI), ghrelin.  Within the brain, receptors for ghrelin, leptin and insulin have been 
identified in the ventromedial hypothalamus (VH).  Signalling by these compounds 
initiating from out with the central nervous system (CNS), ascending to the brain have 
previously been described as afferent signalling (Lustig, 2008).  Briefly, leptin and 
insulin are secreted in the fed state, and have been found to act by, amongst other 
things, increasing the melanocortin receptor 4 (MC4R) occupancy within the CNS.  
Activation of this receptor is associated with increased movement, energy expenditure 
and therefore increased weight loss.   
The complementary descending efferent pathway has been investigated more recently, 
as the principal initiator of lipolysis has only been described within the last 10 years.  In 
a review by Bartness et al. (2010), data showing signals emanating from the CNS, and 
more specifically the sympathetic nervous system (SNS), were involved in the 
inhibition of lipolysis.  As complete shutdown of lipolysis through local inhibition was 
not achievable; another form of innervation was suggested to be controlling white 
adipose tissue lipolysis in mammals.  The SNS was found to act directly on white 
adipose tissue (WAT) and therefore control energy release from adipocytes to a certain 
extent.  Bamshad et al. (1998) as cited in Bartness et al. (2010) identified the brain 
regions involved in the initial innervation of WAT through the utilisation of retrograde 
viral tract tracer pseudorabies virus (PRV).  A trace was performed back along the 
neuron from the central premotor sympathetic neurons revealing the ‘CNS-SNS-WAT’ 
circuit.  To confirm their hypothesis, the Siberian hamster was used to illustrate that 
denervation of SNS neurons blocked WAT lipid mobilisation, and conversely 
increasing melanocortin receptor (a co-localising receptor with SNS outflow neurons) 
agonism resulted in an increase in phosphorylation of HSL and perilipin.  This group 
also identified that whilst the SNS projections originated in the brain, the neuron 
terminals within the adipose tissue were not uniform.  Youngstrom and Bartness (1995) 
demonstrated that WAT SNS innervation depended on many factors including internal 
region of the fat pad (inguinal, epidydymal etc.) and food deprivation.  This irregularity 
was also linked to norepinephrine turnover (NETO), showing that high NETO was 
linked with high levels of adipocyte innervation and vice versa, with an overall 
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influence on the likelihood of lipolysis occurring within adipocytes.  The presence of 
surface receptors, sensitive to such innervation are therefore also important to the 
activity of adipocyte lipolysis.  This is evident in a study showing subcutaneous 
adipocytes isolated from female plastic surgery patients had a large number of α2-AR 
and the highest % inhibition of lipolysis in the presence of a full α2-AR agonist (Castan 
et al., 1994).  Also, the effects of GPCR activation have also been widely documented 
on adipose tissue lipolysis. (Ge 2008) demonstrated that a decrease in % glycerol 
release observed in wild type animals in the presence of SCFA propionate and acetate 
was ablated in GPR43 deficient mice. 
 
Adrenergic receptors: The link between extracellular and intracellular control of 
adipose tissue lipolysis 
There is a complex network of both internal and external pathways involved in TAG 
breakdown, fatty acid and glycerol release as well as re-esterification.  The presence of 
adrenergic receptors (AR) in the membrane of adipocytes is well documented in the 
literature (Collins and Surwit, 2001), and these receptors have been found to act as a 
link between some of the external and internal pathways.  Activators, such as 
catecholamines, increase in abundance after SNS signalling, and are responsible for the 
activation of AR.  There are two main groups of AR, β(1,2,3) and α(1,2), and both of 
these receptors are situated in the cellular membrane and are coupled to a family of 
GPCR.  The GPCR is made up of an α, β and γ subunit.  The two main α subunits 
related to the activation/inhibition of the lipolytic pathway include the stimulatory 
subunit GαS and the inhibitory subunit GαI.  GPCR linked receptors are expressed in 
multiple tissues, as HM47/HM47A has been identified in WAT, spleen and lung of 
humans (Pike, 2005, Tunaru et al., 2003). AR can be more tissue specific, with β3-
receptors more commonly expressed in adipose tissue, compared with β1 and β2 ARs, 
which are expressed throughout human tissues (Collins and Surwit, 2001).  
It has been reported that the ratio of GαI to Gαs may play an important part in regulation 
of lipolysis in adipose tissue.  Factors affecting activation ratio of GPCR have been 
proposed, including type and location of adipose depot, as well as sympathetic 
innervation and norepinephrine turnover (NETO) (Bamshad et al., 1998).  The 
downstream signalling associated with binding of catecholamines to the surface of a β-
AR, such as β3 on adipose tissue depends on the coupled GPCR.  In the case of GαS 
activation, membrane-bound adenylate cyclase would become activated leading to an 
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increase in cAMP availability and subsequent increase in lipolysis. However, if GαI 
were to be stimulated through a β3 agonist, it would result in an inhibitory effect on 
adenylate cyclase. Adenylate cyclase acts as a surface protein linking external activation 
to downstream control of lipolysis.  The stimulatory effect exerted on adenylate cyclase 
by GαS increases circulating cAMP and subsequent increases in PKA phosphorylation 
of downstream proteins and lipases (Fig 1.2).   
 
 
Fig 1.4   The adrenergic G-protein coupled receptor cascade: The involvement of potential 
inhibitory GPCR that may influence cAMP and the subsequent decrease in lipolysis. Gi, 
inhibitory G protein-coupled receptor; cAMP, cyclic adenosine monophosphate; PKA, protein 
kinase A; HSL, hormone sensitive lipase; P, phosphate; ATP, adenosine triphosphate; ADP, 
adenosine diphosphate. 
 
The inhibitory effects of GαI however, decreases overall cAMP levels and therefore 
inhibits PKA activity (Wettschureck and Offermanns, 2005), illustrated in Fig 1.4.  
PKA activation through increased cAMP availability results in the phosphorylation of 
both HSL and perilipin. Both proteins subsequently aid in the hydrolysis of fatty acids 
from the glycerol backbone, increasing overall lipolysis in adipocytes, as reviewed by 
Duncan et al. (2007). 
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GPR43 
GPR43, part of the seven transmembrane receptor super-family has been identified as a 
receptor for SCFA in adipocytes amongst other tissues (Hong et al., 2005).  Ligands 
with the highest efficacy have been identified as acetate (C2) and propionate (C3) (Le 
Poul et al., 2003).  Important tissue specific differences are present between GPR43 and 
its subfamily members GPR40 and GPR41.  GPR43 expression can be seen in a 
multitude of different tissues including spleen, colon, stomach and adipose tissue, 
whereas, GPR41 expression is much more restricted and does not appear to be 
expressed in adipose tissue at all (Hong et al., 2005).  GPR43 has been linked to the GαI 
inhibitory pathway responsible for the inhibition of membrane-associated adenylate 
cyclase (Le Poul et al., 2003) and subsequent reduction in free fatty acid release (Ge et 
al., 2008).  Another important feature of this GPCR subfamily, is evidence to suggest 
that SCFA not only inhibit lipolysis, but also increase lipogenesis.  Acetate has been 
found to contribute to an increase in lipogenic activity influencing the re-esterification 
of fatty acids into triacylglycerides through the activation of GPR43 (Hong et al., 2005).   
Evidence for GPR43 activation of two pathways may be explained by a complementary 
mechanism; as it is possible that activation of GPR43 receptors by SCFA may inhibit 
adipocyte lipolysis, whilst also increasing lipogenesis, both reducing the availability of 
free fatty acids.      
 
HM74A/GPR109A and PUMA-G 
The small human carboxylic acid receptor HM74A/GPR109A and PUMA-G in rodents 
is found at high concentration in white adipose tissue.  In 2003, HM74 was reported by 
Tunaru et al. (2003) to be responsible for the anti-lipolytic function in white adipose 
tissue; however, there is now evidence to suggest the close homologue HM74A is 
responsible for this activity (Zhang et al., 2005).  The ligand with the highest affinity for 
this receptor has been identified as nicotinic acid (NA) and is prescribed regularly in the 
treatment against cardiovascular disease (CVD).  NA has been found to increase 
preferential high-density lipoproteins (HDL) and reduce levels of low-density 
lipoproteins (LDL) and very-LDL (VLDL) with an overall reduction in CVD (Pike, 
2005).  The concentration at which NA is present in the circulation is however, too low 
to act as the endogenous agonist for HM74A (Tunaru et al., 2003).  There is evidence to 
suggest other possible natural ligands.  Due to the similar small carboxylic acid 
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structure common between niacin and the SCFA acetate and propionate, they too may 
possess affinity for HM74A.  
 
EP3 and Prostaglandin E2 
Prostaglandins (PG) are commonly ascribed to the inflammatory response producing 
effects such as flushing and itching. PGE2, derived from arachadonic acid, has been 
identified at high concentrations surrounding adipose tissue.  The prostaglandin receptor 
EP3 has also been found in adipocytes at roughly ten times the concentration of any 
other prostaglandin receptor (Jaworski et al., 2009).  The activation of certain inhibitory 
GPCR and the release of prostaglandins surrounding adipose tissue was investigated by 
Castan et al. (1994).  EP3 found on the surface of adipocytes is activated by PGE2. 
Generation of PGE2 has been linked to the presence of adipose phospholipase A 
(AdPLA).  From reports by Jaworski et al. (2009), it was identified that genetic ablation 
of the Adpla gene in rodent studies resulted in a decrease in WAT mass, supported by 
evidence of a 2-fold increase in cAMP levels compared to wild type rodents.  It was 
also identified that the Adpla null mice had a much lower level of PGE2 in adipose 
tissue compared to wild type and therefore decreased EP3 receptor activation.  This lead 
to the postulation that the decrease in GαI coupled EP3 activation, and consequently, the 
overall increase in cAMP could account for the physiological changes observed in these 
animals.  NEFA and TAG were found to be lower in Adpla null mice contrary to 
expectations.  The molar ratio of fatty acids to glycerol release from WAT was also 
lower in Adpla null mice compared to wild type, however, subsequent experiments 
showed an increase in oxidative metabolism of proteins and an increase in fatty acid 
oxidation of 37 % compared to wild type mice.  The decrease in NEFA and TAG 
appearance in this study were therefore accounted for by an increase in oxidative 
metabolism (Jaworski et al., 2009).  Furthermore, it was identified by Chang-sheng 
Chang (1997) that Chinese hamster ovary (CHO) cells expressing EP3 receptors 
became activated by TEI-3356, containing a negative carboxylic acid terminal, resulting 
in a decrease in cAMP (Jaworski et al., 2009, Chang-sheng Chang, 1997).  Similarities 
can be drawn between the presence of a small carboxyl group in each agonist of the 
GPCR GαI mentioned previously, and a reduction in adipocyte lipolysis.  Speculatively, 
activation of SCFA receptors (GPR43) resulting in a reduction of lipolysis, may be 
compounded if activation of other receptors, such as HM74A and EP3, are susceptible 
to agonists containing a similar carboxyl tail region. However, it should also be 
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considered that side effects for patients commonly prescribed non-steroidal anti-
inflammatory drugs (NSAID), which reduce the presence of natural prostaglandins do 
not include weight gain (NHS, 2012).   
The regulation of lipolysis is complex, and many studies have contributed to our current 
understanding of adipose tissue metabolism and function, as it has been discovered in 
recent years that adipose tissue is much more metabolically active than previously 
thought.  However, there are still gaps in our knowledge.  Due to the increased 
incidence of obesity and related disorders in the UK and worldwide, including type II 
diabetes, experiments on the molecular mechanism(s) underlying such changes in the 
metabolism of adipose tissue are of interest, as they may lead to novel therapeutic 
targets for the treatment of these disorders. The pathway of lipolysis is predominantly 
controlled by two converging mechanisms, GPCR activation and insulin receptor 
activation, with the overall outcome of maintaining adipocyte homeostasis.   Increases 
in acetate availability have been found to affect adipose tissue metabolism by reducing 
lipolysis, as a measure of glycerol and NEFA release, however, at supra-physiological 
concentrations (above 1mM). Identification of adipocyte surface receptors, such as 
GPR43, specific for short chain fatty acids, may therefore be of value when considering 
new therapeutic targets for the side effects of obesity and related disorders.  Interest in 
these receptors has increased as the intracellular mechanism(s) by which SCFA effect 
lipolysis are still unknown.  Receptor activation with physiological concentration of 
SCFA may contribute to overall adipocyte homeostasis; however, it is of interest to 
establish if supra-physiological SCFA acetate availability may induce a beneficial 
response including the reduction of side effects of type II diabetes, including 
dyslipidaemia, as previous studies have shown, that artificially induced acetate 
concentrations, as high as 10 mM reduce lipolysis, as a measure of glycerol and NEFA 
release.  Therefore with the use of the in vitro 3T3-L1 cell line and ex vivo primary 
adipocyte cells, this thesis aims to identify the intracellular mechanism(s) underlying 
the effect of  supra-physiological concentrations of  short chain fatty acid, acetate,  on 
lipolysis, by utilising phosphorylation of the key lipolytic lipase HSL, and comparing 
this with changes to NEFA, glycerol and TAG concentration. 
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Cell culture of murine 3T3-L1 adipocytes 
 
Culture media 
Murine 3T3-L1 cells were purchased frozen in liquid nitrogen from Zen-Bio, at passage 
8. Cells were not expanded past passage 12.  All media used for cell culture were 
acquired from Zen Bio (USA), and therefore the concentration of compounds used in 
each plating media could not be obtained.  Plating medium PM-1-L1 for pre-adipocyte 
cell culture contained Dulbecco’s Modified Eagle Medium (DMEM), high glucose, 
Hydroxyethyl Piperazineethanesulfonic Acid (HEPES) pH 7.4, bovine calf serum 
(BCS), penicillin, streptomycin, amphoterecin B.  Cell differentiation media DM-2-L1 
contained DMEM/Ham’s F-12 (1:1, v/v), HEPES pH 7.4, fetal bovine serum (FBS), 
biotin, pantothenate, human insulin, dexamethasone, penicillin, streptomycin, 
amphoterecin B, isobutylmethylxanthine (IBMX) and PPARγ agonist.  Mature 
adipocyte medium AM-1-L1-PRF contained, DMEM/Ham’s F-12 (1:1, v/v), HEPES 
pH 7.4, FBS, biotin, pantothenate, human insulin, dexamethasone, penicillin, 
streptomycin and amphoterecin B.  With the exception of bovine serum albumin-fatty 
acid free (BSA-FFA) (PAA Cell Culture Company) all treatment reagents were 
purchased from Sigma Aldrich.  DMEM-PRF (phenol red free) supplemented with 2 % 
(w/v) BSA-FFA was the basis of all treatment media.  Isoproterenol hydrochloride was 
reconstituted in dimethyl sulphoxide (DMSO), and sodium acetate was reconstituted in 
sterile water (H2O) before use.  Insulin from bovine pancreas was used throughout at a 
final concentration of 1.34 µM.  Phosphate buffered saline (PBS) solution (20x) was 
prepared by dissolving 22.88 g Na2HPO4; 160.00 g NaCl; 4.00 g KH2PO4  and  4.00 g 
KCl in 1 litre of sterile H2O and adjusting to pH 7.2 with 10 M NaOH.  A 1x solution 
was prepared by diluting 50 ml in 950 ml sterile H2O and filtering before use. 
 
3T3-L1 cell culture 
Cells were fed according to the feeding manual provided by Zen-Bio (2010), following 
precise media changes for each well format.  Cells were plated in PM-1-L1 at a density 
of 5000 cells/cm
2
, in either 6 or 12 well plate formats.  Every two days, 60 % PM-1-L1 
media was aspirated and replaced with 60 % fresh PM-1-L1 media over a period of 5 
days until cells were 100 % confluent.  Cells were then left for a further 48 hrs to 
initiate growth arrest, during which time the media was not changed.  The cells were 
then initiated to differentiate by aspirating all PM-1-L1 and replacing with DM-2-L1.  
The cells were left to incubate for 72 hrs, again during this time the media was not 
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changed.  After differentiation, day 0, 60 % DM-2-L1 was aspirated from each well and 
replaced with 80 % AM-1-L1-PRF.  This occurred every 2 days allowing for a gradual 
change from DM-2-L1 to AM-1-L1-PRF media.  Visualising lipid accumulation using 
the Oil Red O stain, mature 3T3-L1 cells were deemed sufficiently lipid filled for 
treatment on day 9 post-differentiation, within the manufacturers’ guidelines of 7 - 14 
days.  
 
3T3-L1 cell treatment 
On day 9 post-differentiation, cells were washed in 1 x PBS before DMEM-PRF media 
containing 2 % (w/v) BSA-FFA plus a treatment of 1. Basal 2. Sodium acetate (4 mM) 
3. Insulin (1.34 µM) 4. Sodium acetate + Insulin (NaAc+Ins.) 5. Isoproterenol (Iso) (5 
µM) 6. Iso+Acetate 7. Iso+Insulin 8. Iso+NaAc+Ins., unless otherwise stated.  For 
sodium acetate treatments, cells were pre-incubated in the presence of 4 mM acetate for 
30 minutes prior to PBS cell wash step.  Samples of treatment medium were collected 
every 60 minutes over a maximum period of 180 minute and stored on ice.  After the 
last sample was collected, cells were lysed in a 1 x Lysis buffer (Cell Signalling), 
sonicated for 10 x 1 second bursts before being centrifuged at 10,000 x g for 10 minutes 
at 4ºC.  Treatment media samples were stored at -20ºC until ready for glycerol and 
NEFA analysis and cell lysis supernatants were stored at -80˚C until ready for 
triacylglycerol analysis.  Protein concentration was measured in both the pellet and the 
supernatant fractions collected on the same day as sample collection, using the method 
described below. 
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Isolation of primary mature adipocytes 
Culture media 
All cell culture reagents were purchased from Sigma Aldrich with the exception of fatty 
acid free bovine serum albumin (BSA-FFA) and bovine serum albumin (BSA) (PAA 
Cell Culture Company).  Krebs Ringers Bicarbonate Hepes Albumin (KRBHA) 
washing buffer included dissolving 0.5 mM CaCl2, 238 mg/100 ml HEPES, 108 mg/100 
ml Glucose and 3.5 % (w/v) BSA in 100 ml Krebs Ringers Bicarbonate (KRB) buffer 
(Zen Bio KRB-1000).  The tissue digestion buffer (DB) included reconstitution of 0.5 
mM CaCl2, 238 mg/100 ml HEPES and 108 mg/100 ml glucose in 100 ml KRB with 
the addition of 1 mg/ml collagenase (Sigma C6885) and 289 µg/ml liberase (ROCHE 
5401119001) immediately before use.  Mature isolated cells were plated in endothelial 
cell medium (Sigma C1556) containing 0.5 % BSA-FFA. 
 
Mature adipocyte isolation  
All animal work was completed at the Roslin Institute, Edinburgh. An established 
Home Office licence for animal testing at the Roslin Institute covered the euthanasia 
process described for this study. All mice were euthanized by spinal dislocation by a 
trained member of staff with a personal Home Office licence. Fat pad isolation was also 
undertaken at the Roslin Institute, before isolated cells were transported back to Heriot-
Watt University for analysis. No ethical approval was needed for this experiment at 
either institute. 6 x 16 week old female C57BL6/J mice were purchased from Charles 
River on the day of treatment.  After mice were sacrificed by spinal dislocation, 
perigonadal/epididymal (PG/ED) fat pads were excised less than 15 minutes later (Fig 
2.1).  Firstly, each set of fat pads were washed in KRBHA buffer at 37ºC and 
transferred to 5 ml fresh KRBHA.  Fat pads were cut into small 2 - 4 mm pieces and 
placed in 5 ml tissue DB for 45 minutes with continuous shaking at 37ºC.  Isolated 
mature adipocytes were filtered through a 225 µm nylon mesh filter syringe into a 
sterile 15 ml falcon tube and centrifuged for 10 min at 1100 rpm at room temperature.  
It is unlikely at this stage that only adipocytes were isolated during the washing and 
centrifugation steps, and the potential for other cells including macrophages to be 
present should be noted.  Isolated cells were pooled from 6 mice and split between one 
full panel of treatments (basal, acetate, insulin, NaAc+Ins., isoproterenol, Iso+Acetate, 
Iso+Insulin and Iso+NaAc+Ins.) and washed a further 2 times in KRBHA for 1 minute 
at 500 rpm. After the final wash step, 150 µl packed cells were plated in 600 µl plating 
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media in a 12 well plate format.  Cells were then placed at 37ºC for 4 hrs to stabilize 
before the addition of the experimental treatments. All experiments were run in 
duplicate. 
 
Primary mature adipocyte cell treatment 
After isolation and recovery, PG/ED adipocyte cells were subsequently treated with 
sodium acetate.  The plating media of these cells was spiked with 4 mM sodium acetate 
exactly 30 minutes prior to the start of the treatment protocol.  At time 0, each well was 
spiked with a combination of stock isoproterenol (500 µM), acetate (400 mM) and 
insulin (134 µM) to reach a final concentration of 5 µM isoproterenol, 4 mM sodium 
acetate and 1.34 µM insulin.  Samples of treatment media were collected every 60 
minutes over a maximum period of 180 minutes and stored on ice.  After the last sample 
was collected, cells were lysed in a 1 x Lysis buffer (Cell Signalling), sonicated for 10 x 
1 second bursts and centrifuged at 10,000 x g for 10 minutes at 4ºC.  Treatment media 
samples were stored at -20ºC until ready for glycerol and NEFA analysis.  Protein 
concentration was measured on the supernatant fraction collected on the same day as 
sample collection, using the method described below. 
 
 
Fig 2.1   Perigonadal/Epididymal fat pads (arrows) isolated from a 16 week old female 
C57BL6 mouse.  
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Measurement of total protein 
Total protein content for each well was measured in order to allow normalization 
between samples, as mature adipocytes were unable to be counted by haemocytometer. 
Adipose cells are extremely sensitive and cannot have direct contact with glass, as the 
surface tension ruptures the cell wall.  The Bradford method was chosen as it is a one-
step method, sensitive and accurate with most reagents, however a noted disadvantage 
is a non-linear correlation.  This is overcome by generating a new calibration curve 
every time.  By combining the results from both pellet and supernatant fractions we 
were able to account for both membrane bound proteins and soluble intracellular 
proteins.   
 
Bradford reagent 
Bradford reagent was prepared by dissolving 50 mg Coomassie Brilliant Blue (Sigma) 
in 25 ml 95 % ethanol, adding 50 ml 85 % (w/v) phosphoric acid and diluting to a final 
volume of 500 ml. Reagent was filtered before use. 
 
Bovine serum albumin (BSA) standard 
Total protein standards were prepared by dissolving BSA (PAA Cell Culture Company) 
in warmed sterile water at a concentration of 1000 µg/ml.  A set of serial dilutions were 
prepared fresh from the standard everyday including 1000, 500, 250, 125, 63, 31 and 0 
µg/ml. All standards were assayed in triplicate. 
 
Bradford reagent protein assay 
Prior to the determination of total protein, cells were lysed (Cell Signalling Technology) 
on ice for 5 minutes, sonicated for 10 x 1 second bursts and centrifuged at 10 000 x g  
for 10 minutes at 4˚C.  The supernatant was aspirated to a fresh tube and the pellet was 
re-suspended in 100 µl sterile water.  Each pellet and supernatant sample was diluted 1 
in 10 with sterile water before 10 µl was pipetted in triplicate into a flat bottomed 96-
well plate.  Standards were also added to the plate in triplicate.  Bradford reagent, 200 
µl, was added into each well and the plate was read immediately on a SpectraMax M5 
platereader at wavelength 595 nm.  Concentration of total protein in µg/ml was 
calculated using the re-arranged linear equation X = (Y-C)/M, generated from the 
standard curve (Bradford, 1976).  
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Alamar blue (Resazurin) cell cytotoxicity assay 
A 100 x stock solution of resazurin (Sigma) was acquired by reconstituting 1 mg/ml in 1 
x PBS.  The working concentration was achieved by diluting the 100 x stock solution in 
cell culture media and warming to 37ºC before use.  The positive control was achieved 
by making a 1 % (v/v) solution of Triton X-100 in 1 x PBS. 
 
Cell cytotoxicity assay 
Firstly, the positive control was achieved by the addition of 1 % Triton X-100 solution 
to one well and leaving it to incubate for 1 hr prior to incubation with 1 x resazurin.  At 
least one well was left untreated and kept in original AM-1-L1-PRF media throughout 
the duration of the experiment, to be used as the negative control for this assay.  After 
the incubation of the positive control was complete, all cell media was aspirated from 
each well and 0.1 ml/cm
2
 of 1 x resazurin solution was added, followed by a 4, 6 and 20 
hr incubation at 37ºC.  .  
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Lipid staining with Oil Red O 
A stock solution of Oil Red O was prepared by dissolving 0.7 g Oil Red O in 200 ml 
isopropyl alcohol (2-propan-1-ol).  Bakers Formalin was prepared by adding 10 ml 37 
% formaldehyde and 10 ml of 10 % (w/v) calcium chloride aqueous solution to 80 ml of 
sterile water before being mixed and stored at 4ºC.  Glycerol gelatine was prepared by 
adding 5 g gelatin and 50 ml glycerol to 50 ml sterile water before being mixed gently 
at 50ºC.  Glycerol gelatin was also stored at 4ºC, but was heated to 55 - 60ºC before use. 
Harris Hematoxylin (Sigma) and Hanks balanced salt solution (HBSS) were stored at 
4ºC before use.  
 
Oil Red O stain  
Firstly a 60 % Oil Red O solution was prepared by diluting stock Oil Red O with sterile 
water at a ratio of 3:2, and filtering through a Whatman filter paper. Harris hematoxylin 
was also filtered before use.  Treatment media was removed from each well and cells 
were washed 2 - 3 times in HBSS, blotting any extra buffer with a dry paper towel.  
Each well was fixed with 0.2 ml/cm
2
 Bakers Formalin at 4ºC for 30 minutes, after 
which excess fixative was poured off and blotted with dry paper towel.  This was 
followed by the addition of 0.2 ml/cm
2
 60 % Oil Red O to each well and was left to 
incubate for 10 minutes at room temperature.  Excess stain was poured off and wells 
were rinsed under continuous water until the water ran clear.  Excess water was blotted 
with paper towel before the cells were counterstained with Harris Hematoxylin by 
adding 0.2 ml/cm
2
 per well and left to incubate for 2 minutes at room temperature.  
Excess hematoxylin was then poured off and the cells were rinsed under running water 
for 5 minutes.  Excess water was blotted with paper towel and 2 - 3 drops of warmed 
glycerol gelatin was added to each well and topped with a cover slip (Hausman et al., 
2008).  Cells were stained with Oil Red O and fixed on 4 separate days to visualize 
TAG accumulation. 
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Transfection of GFP into mature 3T3-L1 cells 
Reagents 
The treatment media was made using DMEM-PRF, high glucose supplemented with 1 
% antibiotics (Penicillin/Streptomycin).  Stock aliquots of green fluorescent protein 
(GFP) were kept at a concentration of 1 µg/µl and stock Lipofectamine (Invitrogen, 
UK) at a concentration of 1 mg/ml.  A weight of 20 g Mowoil was resuspended in 80 ml 
of PBS pH 7.4, before 40 ml of water free glycerol was added.  This was then left to stir 
over night at room temperature.  Aliquots were then poured and centrifuged at 2500 rpm 
for 30 min.  The supernatant was then removed and frozen at -20ºC until use. 
 
GFP transfection 
For transfection of GFP into 3T3-L1 cells, the cells were initially plated on cover-slips 
in a 24 well plate format.  Pre-adipocytes were grown to confluence and differentiated 
as described on page 16.  Firstly, 4 µl GFP (4 µg) was added to an aliquot of 250 µl 
treatment media in a single micro-tube.  In another micro-tube containing 250 ul 
treatment media, 10 µl of Lipofectamine was added and mixed gently.  Both tubes were 
then left to incubate for 10 min at room temperature.  At the end of the incubation 1 
tube of DNA/media was mixed with 1 tube of Lipofectamine/media, and left to incubate 
for a further 30 min at room temperature.  Medium covering the cells was removed and 
the GFP/Lipofectamine/media mix was added to the cells (~500 µl/well).  Cells were 
left to incubate for a further 48 hrs at 37ºC, 5 % CO2.     
Finally, after 48 hrs incubation, the cells were fixed by initially removing the medium 
from the well followed by washing the cell 3 x with 1 ml PBS.  A small volume of 3 % 
formaldehyde was then added to the cells and left to incubate for 30 min at room 
temperature.  Coverslips were then washed a further 3 x with PBS before being inverted 
and mounted onto glass slides using Mowoil.  
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Measurement of NEFA into culture media 
NEFA accumulation in cell culture media was measured using the following reagents, 
NEFA HR II R1 (434-91795); NEFA HR II R2 (436-91995) and NEFA HR Standard 
(270-77000), and analysed on a SpectraMax M5 plate reader (Amersham Bioscience) at 
550 nm.  Each reagent was provided by WAKO and used according to the manufacturer 
instructions.   
 
NEFA buffers (R1 and R2) 
Buffers R1a and R2a were reconstituted with R1 and R2 respectively.  All reagents 
were mixed thoroughly before use.  The 1 mmol/L standard solution was used for a 1 
point calibration.  Sterile water was used as the blank and this absorbance reading was 
subtracted from all samples and standard absorbance readings.  
 
NEFA assay 
Briefly, to each well of a flat bottomed 96-well plate, 4 µl of sample/standard/blank was 
added in triplicate followed by the addition of 160 µl of reconstituted R1a.  The plate 
was shaken and placed at 37˚C 5 % CO2 for 10 minutes exactly.  The plate was removed 
from the incubator and 80 µl of R2a was pipetted into each well and mixed thoroughly, 
before being incubated again at 37˚C, 5 % CO2 for 10 minutes exactly.  Finally the plate 
was read at 550 nm and all samples were analysed in triplicate.  Concentration of NEFA 
in mmol/L was measured at absorbance 550 nm and calculated according to the 
following equation: 
 
(1) NEFA-HR(2) concentration (mmol/L) = Abs (Sample-Blank) x Standard conc. mmol/L  
     Abs (Standard-Blank) 
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Measurement of glycerol into culture media 
The measurement of glycerol in the cell culture medium was adapted from the original 
paper by  Boobis and Maughan (1983).  
 
Potassium phosphate buffer  
The basis of the potassium phosphate buffer required two separate preparations of 
potassium phosphate: 
1. 10 mM potassium phosphate dibasic (K2HPO4) 
2. 10 mM potassium phosphate monobasic (KH2PO4) 
A volume of 25.02 ml 10mM K2HPO4 was added to 4.98 ml 10mM KH2PO4, before 20 
ml of the combined buffer was diluted in 60 ml sterile water.  Following that, 42.28 g of 
ammonium sulphate (3.2M) was added and the buffer corrected to pH 7.5.  Finally 200 
mg BSA was added and stirred gently until completely dissolved.  The final 
concentration of 2 mM potassium phosphate buffer containing 3.2 M ammonium 
sulphate 2 % BSA (w/v) pH 7.5 was achieved by diluting the buffer to a final volume of 
100 ml with sterile water.  
 
Glycerol buffer 
Firstly, 2 ml hydrazine hydrate was added to 10 ml of 2-amino-2-methypropanol, before 
29.4 mg ethylenediaminetetraacetic acid (EDTA) was added.  Sterile water was then 
added to the buffer before being adjusted to pH 9.9 with HCL and diluting to a final 
volume of 100 ml.  The final concentrations were as follows: 2-amino-2-
methylpropanol (0.1 mol/L), hydrazine hydrate (0.2 mol/L) and EDTA (1 mmol/L) pH 
9.9.  
 
Glycerol assay 
For the measurement of glycerol, the stoichiometric relationship between glycerol and 
NADH has been utilized.  The assay is based on the following reaction: 
Glycerol + NAD
+
 ↔ dihydroxyacetone + NADH + H+ 
The presence of extra NAD+ allows the reaction to proceed to the right. Extra hydrazine 
is present to bring the reaction to completion: 
Dihydroxyacetone + Hydrazine ↔ Dihydroxyacetone-hydrazone 
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Prior to the determination of glycerol, glycerol dehydrogenase (GDH) was reconstituted 
at a concentration of 0.5 U/µl in 2 mM Potassium Phosphate Buffer.  The co-factor 
NAD+ was also reconstituted at 1 mg/30 µl sterile water (50 mM).  Firstly, 
spectrophotometric determination of a single standard was conducted using a 2 mmol/L 
stock solution.  In a 1 ml cuvette 20 µl of GDH and 40 µl NAD+ were added to 1 ml of 
glycerol buffer and mixed thoroughly.  The cuvette was read at 340 nm before 20 µl of 
the 2 mM glycerol standard was added and the contents mixed again.  The cuvette was 
left to incubate for 2.5 hrs in the dark at room temperature before being read at 340 nm.  
The concentration of glycerol in the standard was calculated according to the following 
equations:  
 
(2) Conc. of NADH (M)  = (         Post Abs. – Pre Abs.       ) 
               Molar ext co-efficient of NADH 
Moles per Litre (M/L)  = M/1000 
Concentration (mmol/L) = 10
6 
x M/L concentration 
                µl of sample/standard 
     = mmol/L 
 
Once the precise concentration of the stock standard had been determined, a serial 
dilution was made and used for the subsequent calculation of the glycerol in the 
samples.  For the determination of glycerol in each sample, sufficient reaction mixture 
was made fresh each day.  The reaction mixture consisted of 10 µl GDH and 20 µl 
NAD+ being added to 1 ml Glycerol Buffer before being mixed thoroughly.  To 10 µl 
of sample, blank and standards in a 96-well plate, 40 µl of reaction mixture was added 
to each well, mixed thoroughly and left to incubate in the dark at room temperature for 
4hrs and 30 minutes, double the time used for the 2 mM standard to reach plateau.  
After incubation, 200 µl of sterile H2O was added to each well and the contents 
thoroughly mixed.  Fluorescence was then measured at excitation 340 nm and emission 
460 nm and glycerol concentration of samples calculated from the standard curve using 
the rearranged linear equation X = (Y-C)/M and corrected for dilution (Boobis and 
Maughan, 1983).     
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Trapezoid calculation for total NEFA and glycerol in culture media 
Calculating the area under the curve 
The following trapezium rule, as described by Matthews et al. (1990), was used to 
calculate the total concentration of NEFA and glycerol from 3T3-L1 cells in the 
presence of treatment conditions over time. If we have a NEFA/glycerol concentration 
of y1 and y2 occurring at time points, t1 and t2, the area under the curve (AUC) is the 
product of the two time differences and the average of the two measurements. To 
calculate total accumulation over 180 min at 60 min intervals, the AUC of 0 - 60, 60 - 
120 and 120 -180 min are added together: 
 
(3) Trapezoidal Rule =  (y1+y2) / 2 * (t2-t1) 
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Measurement of intracellular triacylglycerol  
For the measurement of intracellular triacylglycerol all reagents and chemicals were 
supplied by Cayman Chemicals.  The Triglyceride Colorimetric Assay kit (Cambridge 
Bioscience CAY10010303) was used to calculate triglyceride in mg/dl according to the 
manufacturer instructions. 
 
Standard diluent assay reagent 
For the final buffer 4ml of the salt solution (5x) was diluted with 16 ml sterile water 
before using to re-suspend adherent cells and preparing the triglyceride standards.  
 
Sodium phosphate assay buffer 
For the final buffer 4ml of the 250 mM sodium phosphate solution (5x) was diluted with 
16 ml sterile water for use when preparing the triglyceride enzyme solution. 
 
Triglyceride enzyme mixture 
The enzyme mixture was prepared by firstly reconstituting the contents of the vial in 1 
ml sterile water in a 15 ml falcon tube wrapped in tin foil.  To this, 14 ml of diluted 
sodium phosphate buffer was added and mixed by inversion.  
 
Standard preparation 
From the standard supplied with the kit an initial dilution of 1:5 was prepared by adding 
100 µl triglyceride standard (1000 mg/dl) to 400 µl standard diluent.  From the resulting 
200 mg/dl standard solution a serial dilution was performed to achieve a final standard 
curve including 200, 100, 50, 25, 12.5, 6.25, 3.125 and 0 mg/dl.  
 
Triglyceride assay 
Prior to the start of the assay cells were washed in ice cold 1 x PBS. To each well, 104 
µl/ cm
2 
of ice cold standard diluent was added.  Cells were scraped into suspension with 
a rubber cell scraper before the cell suspension was sonicated 20 times in one second 
bursts.  The cell suspension was centrifuged at 10,000 x g for 10 minutes at 4˚C, before 
the supernatant was removed and stored on ice.  The eight standards mentioned above 
were prepared and 10 µl of each was pipetted in duplicate into the 96 well plate 
provided.  As cell lysis released all stored triacylglycerol into the cell suspension it was 
important to warm the samples to 37ºC before pipetting any sample into the plate, as 
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centrifugation at 4ºC to remove the cell membrane fraction also solidified the lipids.  
Once the lipids were back in suspension, 10 µl of sample was pipetted in duplicate.  To 
initiate the assay, 150 µl of diluted triglyceride enzyme mixture was added to each well.  
The plate was then shaken for a few seconds, covered with the plate cover and 
incubated at room temperature for 15 minutes.  The plate was then read at 550 nm and 
total triglyceride content was calculated according to the following equation, corrected 
for dilutions and normalised to total protein: 
 
(4) Triglyceride (mg/dl) = (Corrected absorbance) – (y-intercept) 
               Slope   
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Western blotting  
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
Running buffer 
A 10 x stock solution of running buffer was made by dissolving 30.3 g Trizma base, 
144 g glycine and 10 g SDS in 1 L sterile water.  The final 1 x running buffer consisted 
of 100 ml 10 x running buffer diluted in 900 ml sterile water to obtain a final 
concentration of 25 mM trizma base, 192 mM Glycine and 0.1 % (w/v) SDS.    
  
Lysis buffer 
A 10 x lysis buffer was obtained from Cell Signalling (Cat. 9803).  Sterile water was 
used to dilute the 10 x lysis buffer to a 1 x solution and cooled on ice before use.  
Protease inhibitors such as phenylmethanesulfonyl fluoride (PMSF) (Sigma P2676) 
were added at a final concentration of 1 mM immediately before use.  
 
Sample buffer 
A 2 x Tris-Glycine SDS sample buffer was obtained from Invitrogen (Cat.LC2676). 
Sample buffer was added directly to samples at a ratio of 1:2. 
 
Preparation of lysates 
Firstly, cells were washed in ice cold 1 x PBS. To each well, 200 µl 1 x Lysis buffer 
was added and left to incubate on ice for 5 minutes.  Cells were then scraped into buffer 
and centrifuged at 10,000 x g for 10 minutes at 4°C.  Due to the release of 
triacylglycerol from the intracellular lipid droplets, the middle supranatant layer was 
aspirated carefully and centrifuged under the same conditions for a second time.   
 
Electrophoresis 
Samples were mixed with 2 x sample buffer at a ratio of 1:2 before boiling at 100°C for 
5 minutes.  Samples were flash cooled for 5 minutes on ice before loading into 9 - 15 % 
SDS PAGE mini-PROTEAN TGX™ pre-cast gels.  Electrophoresis was carried out in a 
mini-PROTEAN Tetra System at 200 V for 40 minutes, or until the bromophenol blue 
dye reached the bottom of the gel.  
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Protein transfer  
Transfer buffer 
A 10 x stock solution of transfer buffer was made by dissolving 30.3 g Trizma Base and 
144 g glycine in 1 L sterile water.  The final 1 x transfer buffer was achieved by diluting 
100 ml 10 x transfer buffer in 900 ml sterile water to obtain a final concentration of 25 
mM Trizma Base and 192 mM glycine.  
 
Washing buffer – Tris buffered saline with Tween 20 (TBS-T) 
To achieve the final 1 x TBS-T, two buffers were needed.  A stock solution of 0.5 M 
Trizma Base pH 7.5 was made by dissolving 30.3 g Trizma base in 500 ml sterile water, 
HCL
-
 was used to pH to 7.5. The stock solution of 5 M NaCl was made by dissolving 
146.1 g NaCl in 500 ml sterile water.  Firstly a 1 x TBS concentration of 20 mM Trizma 
Base and 150 mM NaCl was achieved by diluting 40ml 0.5 M Trizma Base (pH 7.5) 
and 30 ml 5 M NaCl in 930 ml sterile water. To 999 ml of 1 x TBS, 1 ml Tween 20 was 
added and mixed thoroughly. TBS-T was chilled to 4°C before use.      
 
Blocking buffer 
Non-fat dried milk powder (Marvel) was used as a blocking agent at a concentration of 
5 % (w/v) in TBS-T. This was prepared fresh on the day of use. 
 
Detection reagents 
LumiGLO detection reagent was purchased from Cell Signalling (#7003) and prepared 
by the addition of two reagents.  Immediately before use, 0.5 ml 20 X LumiGLO and 
0.5 ml 20 X Peroxide were diluted in 9 ml dH2O and mixed by inversion.   
 
Protein transfer 
Proteins separated by SDS-PAGE were transferred to polyvinylidene fluoride (PVDF) 
membrane prior to protein detection using specific antibodies.  Sponges used for 
transfer were equilibrated in buffer for 20 minutes prior to the start of transfer.  PVDF 
membrane was activated by soaking in 100 % methanol for 1 minute and subsequently 
washed in distilled water for 5 minutes before being equilibrated in transfer buffer for 
20 minutes.  Filter pads were soaked in transfer buffer for 1 minute prior to transfer.  
Before transfer, gels were briefly washed in distilled water.  The proteins were 
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transferred using the Bio-Rad mini-PROTEAN Tetra System for 40 minutes at 100 V in 
a cooled unit using ice packs and stirrer.        
 
Antibody detection 
Phosphorylated hormone sensitive lipase (SER563) was visualised on PVDF 
membranes using the pHSL(SER563) primary antibody from Cell Signalling (#4139).  
After protein transfer to PVDF, the membranes were washed 1 x 5 min in TBS-T before 
blocking over night at 4°C on a shaking platform.  To ensure equal amounts of protein 
were added to each lane the membranes were also probed for GAPDH (14C10) as a 
loading control (Cell Signalling #2118).  The following day membranes were washed 2 
x 2 min in TBS-T before cutting the membrane at a point between the protein of interest 
and loading control.  Primary antibodies for pHSL(SER563) (1:1000) and GAPDH 
(14C10) (1:1000) were prepared in TBST-T 5 % milk powder and membranes 
incubated for 1 hr on a rocking platform at room temperature.  Membranes were then 
washed again 6 x for 5 min in TBS-T before the addition of the secondary antibody 
anti-rabbit IgG HRP linked (1:3000) in TBS-T 2 % milk powder were incubated for 1 hr 
on a rocking platform at room temperature.  Membranes were washed for a final time 6 
x 5 min in TBS-T before detection reagents were added. LumiGLO reagents were kept 
on ice and prepared immediately before use. To each membrane, 10 ml of 1 x detection 
reagent was added and incubated for 1 minute before blotting excess reagent and 
placing membranes between two clear acetate sheets. Membranes were visualized on a 
Bio-Rad ChemiDoc XRS+ Imager using Image Lab 2.0 software for analysis.  
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Introduction 
The 3T3-L1 cell line has been utilised and optimised as an experimental model since the 
mid-1970s (Green and Kehinde, 1976, Green and Kehinde, 1975, Green and Meuth, 
1974) cited by Lafontan (2012), and was first isolated from Swiss 3T3 mouse embryos.  
Since then, the 3T3-L1 cell line is now commonly used to study the metabolic function 
of mature adipocytes (Berggreen et al., 2009, Ge et al., 2008, Mulder et al., 2005, Lasa 
et al., 2012).  
Within the literature, the use of a stimulator of lipolysis is common when studying 
surface receptor activation and metabolic function of adipose tissue, either in vivo or in 
vitro (Mulder et al., 2005, Tavernier et al., 2005, Youngstrom and Bartness, 1995, 
Koppo et al., 2012, Collins and Surwit, 2001, Collins et al., 2004).  Adipocyte 
stimulation can be induced through activation of surface receptors by endogenous 
catecholamines, however, the synthetic alternative isoproterenol is also commonly used 
(Daval et al., 2005, Hong et al., 2005, Yin et al., 2003).  The concentration of 
isoproterenol used to induce adipocyte lipolysis varies within the literature, as 
evidenced by Hong et al. (2005) utilising 100 nm and Daval et al. (2005) and Yin et al. 
(2003) utilising 1 µM and 10 µM, respectively.  In vitro activation of the lipolytic 
pathway results in an accumulation of NEFA and glycerol into cell culture media.  
Studies have utilised the release of these by-products as a measure of change in lipolysis 
for many years (Nilsson and Belfrage, 1978, Björntorp, 1966). The assays used to 
measure levels of NEFA and glycerol  are extremely sensitive, with a capacity to 
measure nmole changes in concentration. More recently, changes in protein levels and 
second messenger concentrations, can be assessed, including HSL and cAMP (Daval et 
al., 2005, Zhou et al., 2011). 
The use of ex vivo preparations of mature adipocytes are also used to study the effects of 
treatments on adipocyte metabolism, including lipolysis.  Both mature adipocytes and 
stromal vascular cell (SVC) factions can be utilised after excision of the fat pad of 
interest, as reviewed by Lafontan (2012).  The SVC fraction can be filtered to isolate the 
pre-adipocyte cell fraction and plated before the process of differentiation can occur.  
The isolation of mature primary adipocytes is also complex and requires a number of 
techniques and reagents in order to achieve a high yield of cells and maintain cell 
viability (Rodbell, 1964, Hausman et al., 2008, Ruan et al., 2003).  
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NEFA, glycerol and TAG assays were chosen as an initial measure of changes in 
lipolysis, in the presence of the selected treatment compounds isoproterenol, insulin and 
acetate. Furthermore, as there was no indication within the NEFA assay manufacturer’s 
instructions regarding potential interference of isoproterenol, acetate or insulin, it was 
hypothesised that isoproterenol, acetate and insulin, either individually or in 
combination would not significantly interfere with the absorbance reading of the 
sample.  Due to a lack of information in the literature regarding the concentration 
required to half maximally stimulate (EC50) NEFA and/or glycerol release from 3T3-L1 
cells with the β-AR stimulator isoproterenol, it was hypothesised that 5 µM 
isoproterenol would produce half maximal stimulation of lipolysis, and that under 
stimulated conditions, 2 mM sodium acetate would significantly reduce NEFA and 
glycerol accumulation in the media.  It was also hypothesised that the expression of 
phosphorylated HSL (pHSLSER563) in 3T3-L1 cells would increase in isoproterenol 
stimulated cells compared with the basal state, but that expression of GAPDH would 
remain unaffected. Finally, it was hypothesised that mature primary adipocytes from 16 
week female C57BL6 mice would be most viable after isolation in a combination of 
both collagenase and liberase.  
 
Statistical analysis 
All statistical analysis was performed using IBM SPSS Statistics 20 software. All data 
were analysed for outliers using boxplots before testing for normality.  Data with <50 
samples were tested for normality using the Shapiro-Wilk test and data with >50 
samples were checked for normality using the Kolmogorov-Smirnov test.  Normally 
distributed data that included both treatment and time parameters were analysed using a 
2-Way analysis of variance (ANOVA) whereas data that included only a treatment 
parameter were analysed using a 1-Way ANOVA. Both tests included a post-hoc Tukey 
test.  For non-parametric data analysis, all samples were deemed independent of each 
other, and so a Kruskal-Wallis test was conducted followed by pair-wise Mann-Whitney 
analysis.  The mean and standard error of the mean (SE) were used to graph data found 
to be normally distributed whereas median and quartiles were used for data found to be 
non-parametric.  A P value of ≤ 0.05 was considered statistically significant. 
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Results 
3T3-L1 cell lipid deposition  
Over a period of 8 days post-differentiation, it was clear there was an increase in 
accumulation of triacylglycerol as shown by Oil Red O staining in Fig 3.1 A, B, C and 
D.  In the early stage of differentiation (Fig 3.1 A) only a few cells contained lipid 
droplets and many still exhibited the long projections from the cell body as seen in pre-
adipocytes.  After 3 days post-differentiation (Fig 3.1, B), cells were starting to store 
TAG in multiple small lipid droplets.  The majority of these cells had lost their 
fibroblast-like spiny projections and were forming the recognisable spherical shape of 
mature adipocytes.  By day 5 post-differentiation (Fig 3.1, C), the majority of mature 
adipocytes contained lipid droplets, however the distribution of lipid deposition was not 
equal between fat cells.  At day 8 post-differentiation (Fig 3.1, D), most mature 
adipocytes contained lipid droplets and were sufficiently lipid filled to be used in 
subsequent experiments. 
 
Fig. 3.1   Differentiated mature 3T3-L1 cells stained with Oil Red O. A. Day 1 post-
differentiation B. Day 3 post-differentiation C. Day 5 post-differentiation D. Day 8 post-
differentiation. Pictures were taken on a Zeiss Axiovert 40C inverted light microscope under 
10X magnification.  
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Lipid droplets also appeared fuller than those in day 5 post-differentiation.  In order to 
confirm sufficient lipid accumulation throughout the whole cell, which could not be 
achieved using standard microscopy techniques, transfection with green fluorescent 
protein (GFP) was performed.  
From the transfection of GFP into day 9 post-differentiated 3T3-L1 cells, it was 
possible to visualise multiple lipid droplet formations of varying size through a cross 
section of the cell (see Fig. 3.2), with the nucleus present at the edge of the cell wall 
(arrow).  In order to identify if the lipid droplets varied in size throughout the whole 
adipocyte, a visual stack of images was acquired on a Leica SP5 SMD confocal laser 
scanning microscope. Sections were taken every 0.258 µm, and as shown in Fig. 3.3, 
lipid droplets appear to vary in size throughout the whole cell. In contrast to Fig 3.2, the 
nucleus of cell imaged in Fig. 3.3 appears to be in the centre of the cell. 
 
 
Fig. 3.2   Day 9 post-differentiated 3T3-L1 cell transfected with 4 µg GFP for 48 hrs. Arrow 
indicates cell nucleus.  
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Fig. 3.3   Day 9 post-differentiation 3T3-L1 cells transfected with 4 µg GFP for 48 hrs. Stack 
images through the cell in 0.258 µm sections.  
 
Isoproterenol titration on NEFA and glycerol (3T3-L1 cells) 
From Fig. 3.4, it was clear that NEFA increased significantly in the presence of each 
dose of isoproterenol compared with 0 µM after a 120 min incubation (6.25 µM P = 
0.050; 12.5 µM P = 0.050; 25 µM P = 0.050; 50 µM P = 0.050 and 100 µM P = 0.050 
vs. 0 µM).  However, there was no significant difference in NEFA  between 6.25 µM 
and 100 µM isoproterenol (6.25 µM vs. 12.5 µM P = 0.127; 12.5 µM vs. 25 µM P = 
0.827; 25 µM vs. 50 µM P = 0.513 and 50 µM vs. 100 µM P = 0.127).  In Fig. 3.4, 
incubation with 12.5 µM isoproterenol resulted in an accumulation of 1.79 µmol/mg 
protein of NEFA, after 120 min, compared with 20.87 µmol/mg protein in the presence 
of 10 µM isoproterenol in Fig. 3.6, a 15 fold reduction in NEFA .  However, this change 
is possibly due to a difference in the total protein calculated from each sample.  There is 
evidence to suggest the supernatant fraction of cell lysates can contain ≥ protein than in 
the insoluble pellet fraction.  A lack of protein data from the supernatant fraction of 
samples used in Fig. 3.6 may have artificially increased the level of NEFA calculated in 
the presence of 10 µM isoproterenol in Fig. 3.4.  
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Fig. 3.4   NEFA increased significantly until 6.25 µM isoproterenol, before NEFA concentration 
plateaued.  Mature 3T3-L1 cells were incubated in the presence of increasing doses of 
isoproterenol for 120 min.  Lowercase letters shared in common indicate no significance, data 
expressed as median and quartiles, P ≤ 0.05. n = 3.  
 
Glycerol was also measured in the presence of increasing concentrations of 
isoproterenol after 120 min incubation (see Fig 3.5) and these data exhibit a similar 
pattern to NEFA.  Glycerol concentration did not significantly increase after 12.5 µM 
isoproterenol, compared with 25 µM (P = 0.695); 50 µM (P = 0.638) and 100 µM (P = 
0.437).  There was however, a significant increase in glycerol from when exposed to 0 
µM to 6.25 µM isoproterenol (P = 0.002) and from 6.25 µM to 12.5 µM isoproterenol 
(P = 0.039). There was also a significant increase in concentration of glycerol release 
after 120 min, between 6.25 and 100 µM isoproterenol (P = 0.046).  In Fig. 3.6, in 
comparison with isoproterenol alone, in the presence of 10 µM isoproterenol plus 4 mM 
acetate, there does not appear to be a change in the concentration of NEFA at any time 
point over the 240 min incubation.  
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Fig. 3.5   Isoproterenol increased glycerol concentration in a dose dependent manner until 
~12.5 µM.  Mature 3T3-L1 cells were incubated in the presence of increasing doses of 
isoproterenol for 120 min.  Lowercase letters shared in common indicate no significance P ≤ 
0.05. n = 3. 
 
 
 
  
Fig 3.6   3T3-L1 cells stimulated with 10 µm isoproterenol in the presence or absence of 4 mM 
sodium acetate. n = 1-2.  
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The effect of sodium acetate titration on the change in NEFA and glycerol (3T3-L1 
cells) 
As shown in Fig. 3.7 at 60 min, sodium acetate did not result in a significant effect on 
NEFA compared with 5 µM isoproterenol alone.  However, at 120 min the presence of 
4 mM and 6 mM sodium acetate resulted in a significant reduction in NEFA  compared 
with isoproterenol alone (P = 0.039; P = 0.039, respectively).  By 180 min, 2, 6 and 8 
mM sodium acetate had resulted in a significant reduction in NEFA concentration 
compared with isoproterenol (2 mM, P = 0.05; 6 mM, P = 0.05 and 8 mM, P = 0.05 vs. 
isoproterenol).  The change in glycerol concentration in the media from 3T3-L1 cells in 
the presence of 2, 4, 6 and 8 mM sodium did not differ significantly from glycerol in the 
presence of isoproterenol alone at 60, 120 and 180 min (see Fig. 3.8).    
 
 
 
Fig. 3.7   At 120 and 180 min, under stimulated conditions NEFA was reduced in the presence 
of sodium acetate. Change in concentration was calculated by subtracting 0 min from each 
subsequent time point. Values are median and quartiles, *P < 0.05 vs. isoproterenol. n = 3 - 6.  
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Fig. 3.8   Sodium acetate resulted in a reduction in glycerol in the media from cells incubated 
under stimulated conditions at 60 min.  Change in glycerol was calculated by subtracting 0 min 
from each subsequent time point. Values are means ± SE, n = 3 - 6.  
 
The effect of sodium acetate titration on total NEFA and total glycerol in cell 
media 
After calculating the total concentration of NEFA and glycerol during 0 to 180 min 
sodium acetate treatment inclusive (Trapezoid calculation); 2mM, 4mM, 6mM and 
8mM sodium acetate resulted in a significant reduction in NEFA compared with 
isoproterenol treated cells alone (P = 0.016; P = 0.019; P = 0.003 and P = 0.012, 
respectively), see Fig. 3.9.  Due to a lack of significant change in glycerol over time in 
Fig 3.8, there was also no significant change in total glycerol concentration in the 
presence of each sodium acetate concentration (see Fig 3.10).  Compared with 
isoproterenol alone, the addition of either 2 mM, 4 mM, 6mM or 8 mM sodium acetate 
did not significantly reduce total glycerol (P = 0.994; P = 0.969, P = 0.711 and P = 
0.688 vs. isoproterenol, respectively).   
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Fig. 3.9   Total NEFA was significantly reduced in the presence of 2, 4, 6, 8 mM sodium acetate 
compared with isoproterenol alone. Values are means ± SE, *P < 0.05 vs. isoproterenol, n = 3. 
 
 
Fig 3.10   The presence of 2, 4, 6 and 8 mM sodium acetate did not reduce total glycerol 
significantly, compared with isoproterenol alone. Values are means ± SE,  n = 3. 
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Western blot analysis 
Protein titration 
In Fig 3.11, it was apparent that isoproterenol resulted in a substantial increase in 
phosphorylation of pHSL(SER563) as expected, however isoproterenol treatment did not 
change the level of GAPDH and therefore was unaffected by treatment conditions and 
could be used as a reliable loading control.  
 
Fig. 3.11   Isoproterenol resulted in an increase in the level of pHSL present in each sample; 
however isoproterenol did not affect the level of GAPDH.  n = 1.   
 
From Fig 3.12 there appears to be no noticeable difference in pixel signal intensity from 
GAPDH between 30 and 40 µg protein, but by 50 µg the definition of the image had 
become less clear.  Therefore an acceptable range of protein volume to use in 
subsequent samples would be 15 - 30 µg protein as the potential for pixel bleaching is 
minimised at this volume.  
 
Fig 3.12   Increasing the volume of protein per sample above 40 µg resulted in an increase in the 
potential for pixel bleaching of GAPDH.  Mature 3T3-L1 cells were incubated for 120 min in 
basal media. n = 1. 
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Temporal resolution of the basal activity of 3T3-L1 cells 
Under basal conditions, the highest peak of phosphorylation of HSL occurred at 120 
min compared to time 0 as shown in Fig. 3.13.  The level of HSL phosphorylation 
occurring at 150, 180 and 210 appears to have become reduced compared to 0 min, 
however due to the lack of repeat experiments statistical analysis could not be 
performed on this data.    
 
Fig 3.13   Under basal conditions, phosphorylation of HSL occurred at its highest level at 120 
min, compared to time 0 min.  n = 1.  
 
Temporal resolution of the stimulated activity of 3T3-L1 cells 
As shown in Fig 3.14, in the presence of isoproterenol (5 µM), the relative volume of 
pixel intensity of pHSL increased ~8 fold between 0 min and 60 min incubation.  The 
relative volume of pixel intensity of pHSL decreased ~25 % between 60 and 90 min, 
and by ~20 % between 120 and 150 min.  After 150 min incubation the level of pHSL is 
still ~4.7 fold higher than that observed at time 0 min.  Sample containing 25 µg protein 
was loaded into each well.  To ensure that the relative volume of pixel intensity of HSL 
phosphorylation in each sample was comparable between treatments, all samples were 
normalised relative to GAPDH,  
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Fig. 3.14   A. Relative volume of pHSL increased by ~90 % in the presence of 5 µM 
isoproterenol after 60 min incubation.  B. After 30 min incubation, relative volume of pHSL 
increased ~ 91 % in the presence of 5µM isoproterenol.  C. Combining data from both A. and B. 
demonstrates that after 30 min in the presence of isoproterenol (5µM), relative volume of pHSL 
has increase by ~ 94 %.  n = 1 - 2. 
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Isoproterenol, acetate and insulin interference with NEFA assay (in the absence of 
3T3-L1 cells) 
In Fig. 3.15, the effects of basal media spiked with either acetate, insulin or NaAc+Ins., 
did not result in a significant difference in NEFA concentration compared with basal 
media alone (P = 0.244, P = 0.182 and P = 0.609 respectively).  As shown in Fig. 3.16, 
Isoproterenol, Iso+Acetate, Iso+Insulin and Iso+NaAc.+Ins. also did not cause a 
significant change in NEFA concentration compared with basal media alone (P = 0.311, 
P = 0.082, P = 0.219 and P = 0.185 vs. basal respectively).  
 
Fig. 3.15   In basal medium, the presence of acetate and NaAc+Ins., did not result in a 
significant change in the background absorbance of the NEFA assay.  Data are Mean ± SE, *P < 
0.05, n = 4 - 7.  
 
 
Fig. 3.16   In basal medium, the presence of isoproterenol, acetate, insulin and NaAc+Ins. did 
not result in a significant change in background absorbance of the NEFA assay.  Data are 
Median and quartiles, n = 4 - 8. 
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NEFA assay interference over 120 minutes 
It would appear that the treatment compounds, acetate and insulin, do not interfere with 
the baseline NEFA concentration found in media collected from isoproterenol 
stimulated cell alone, after a 120 min incubation (See Fig. 3.17).  Samples were spiked 
with acetate and insulin before measurement of NEFA concentration. 
 
Fig. 3.17   Treatment compounds did not interfere with NEFA assay after 120 min incubation.  
Stimulated cell media was spiked with or without sodium acetate (4mM) and with or without 
insulin (1.34 µM). Due to a lack of repeat experiments, statistical analysis could not be 
performed. n = 1.   
 
The effect of lysis buffer interference on total protein calculation (in the absence of 
3T3-L1 cells) 
From the results in Fig. 3.18, it is apparent that in its concentrated form, the 10x stock 
solution of lysis buffer resulted in a ~ 4.6 fold increase in the absorbance reading for the 
total protein reagent (Coomasie Blue) compared to sterile water at absorbance 595nm.  
The concentration recommended by the manufacturer was a 1x solution; however, this 
concentration also resulted in a ~3.5 fold background reading of absorbance compared 
to water.  In order for the cell suspension and pellet samples collected in subsequent 
studies to be analysed within the linear element of the BSA standard curve, all samples 
were diluted a further 10 fold in sterile water.  To replicate these conditions a 10 fold 
dilution of the 1x lysis buffer was analysed and was found to have a background 
absorbance similar to that found in sterile water (see Fig. 3.19.).  
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Fig. 3.18   Cell lysis buffer at the concentration used during total protein analysis did not 
interfere with the absorbance reading at 595 nm. n = 1.   
 
 
Fig. 3.19   Cell lysis buffer did not interfere with total protein calculation when diluted 10 fold 
in sterile water. n = 1. 
 
Primary cell isolation – Cytotoxicity  
As shown in Fig. 3.20A, after 4 hrs incubating in three different combinations of 
digestion buffer (DB1, DB2 and DB3); cells isolated with both collagenase + liberase 
(DB3) were most viable, illustrated by a change in the cell media from blue to pink 
illustrating a change in resazurin (blue) to resorufin (pink) (O'Brien et al., 2000).  In Fig. 
3.20 B, after a 6 hr incubation, both DB3 wells 1 and 2 had changed from blue to pink.  
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In the presence of DB1, collagenase alone, the cells were able to metabolise resazurin to 
resorufin after 20 hrs post-isolation (Fig. 3.20 C).  However, cells isolated in DB2 did 
not show any sign of metabolism, as cell media containing resazurin remained blue at 
all three time points (Fig 3.20 A,B,C).  As expected cells incubated in Triton-X100 for 1 
hr did not metabolise resazurin to resorufin and therefore remained blue.  Also, after 20 
hrs incubation, in Fig. 3.20C, DB3 well 1 had become colourless   as resorufin was 
finally metabolised to hydroresorufin..  
   
Fig. 3.20   Measure of cell cytotoxicity after dissection and isolation of mature primary 
adipocytes.  A. 4 hr post isolation.  B. 6 hr post isolation.  C. 20 hr post isolation.  Cells were 
isolated in 3 various digestion buffers; DB1 Collagenase (1mg/ml); DB2 Liberase (0.15 Wünsch 
units); DB3 Collagenase (1 mg/ml) + Liberase (0.15 Wünsch units).  n = 2 - 3.   
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Discussion 
There were many reasons for conducting these studies, and one of the first was to 
understand the physiology of the 3T3-L1 cell line, including the maturation process of 
lipid droplet formation.  The second was to ascertain whether the proposed treatment 
conditions would result in interference with the metabolic assays.  And finally, studies 
using techniques such as western blotting were conducted to map any changes in protein 
expression over time and to confirm the protein GAPDH as a loading control. 
From the literature, it was identified that 3T3-L1 cells could be utilised for experiments 
at different stages of cell maturity, evidenced by the use of mature cells on different 
days post-differentiation (Ge et al., 2008, Cao et al., 2007).  It is understood that this 
particular cell line can be used between days 7 and 14 post-differentiation (Zen-Bio, 
2012); and it is clear in Fig. 3.1, that the level of TAG incorporated into lipid droplets 
increases greatly before this time, Fig. 3.1 A-D.  Due to the increase in lipid 
accumulation within lipid droplets observed in Fig 3.1 A-D, the number of days post-
differentiation cells are experimented on, may impact on the results obtained.  
Therefore, all subsequent studies involving the use of 3T3-L1 cells were conducted on 
the same day (9 days post-differentiation).  Also, as shown in Fig. 3.5 and Fig. 3.6, the 
concentration required to stimulated lipolysis by 100 % was established for 
isoproterenol in both the glycerol and NEFA assays.  It was apparent from the data that 
~10 µM isoproterenol was required to stimulate lipolysis by 100 %, a concentration 
commonly used by others (Rodríguez et al., 2011, Lasa et al., 2012). From the results it 
was apparent that there was not a linear relationship between the dose required to 
stimulate NEFA and glycerol release. Therefore the EC50 (concentration required to 
stimulate a reaction by 50 %) could not be calculated.  From data in Fig. 3.6 in the 
presence of 10 µM isoproterenol, 4 mM acetate was unable to reduce NEFA release, 
therefore, for subsequent experiments it was suggested that a submaximal concentration 
of isoproterenol be used. For this reason a concentration of 5 µM would be used..  It 
was also identified that the supernatant fraction of the cell lysate contained soluble 
protein as measured by the Bradford reagent technique.  All subsequent tests were 
conducted with the inclusion of both pellet and supernatant fractions when normalising 
by-products of lipolysis (NEFA, glycerol, TAG) to total protein.  From the literature, 
studies have also reported data collected after the administration of a range of 
concentrations of acetate (Ferchaud-Roucher et al., 2005, Nuutinen et al., 1985, Nilsson 
and Belfrage, 1978), therefore as sodium acetate was the treatment of interest, a dose 
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response relationship in the presence of 5 µM isoproterenol was also completed.  In the 
presence of 2, 4, 6 and 8 mM sodium acetate, NEFA was measured every 60 min for 3 
hrs.  From the results shown in Fig. 3.9, after 180 min incubation, total NEFA was 
significantly reduced by all concentrations of sodium acetate (2, 4, 6 and 8mM); 
however, as shown in Fig 3.7, at 120 min, only 4 mM and 6 mM sodium acetate 
reduced NEFA significantly.  For this reason 4 mM sodium acetate was used in all 
subsequent experiments. It should also be noted that this concentration of acetate would 
be regarded as supra-physiological, and would not occur naturally in humans. 
Therefore, all subsequent data should be analysed on the understanding that the effects 
observed would only occur in circumstances where acetate had been artificially 
increased, for investigation into therapeutic targets.    
Many factors influence the reliability of the western blot technique e.g. gel running and 
transfer times, blocking time and specificity of antibodies.  Firstly, as seen in Fig. 3.11, 
GAPDH was chosen as a loading control as it was unaffected by the treatment of cells 
with isoproterenol.  Secondly, it was important to identify the most appropriate 
concentration of protein to use, as seen in Fig. 3.12.  Finally, as the metabolic studies 
were conducted over a 180 min incubation, an appropriate time point to stop treatment 
incubation for the purpose of western blot analysis was chosen.  From Fig. 3.13, under 
basal conditions, pHSL phosphorylation was highest at 120 min; however there was no 
data for earlier time points.  The data in Fig. 3.14 C, under stimulated conditions, 
however, showed that pHSL peaked at 30 min and decreased until 90 min where 
phosphorylation appeared to plateau.  Metabolic sampling at 0, 60, 120 and 180 min had 
concluded prior to the start of western blot analysis.  Therefore, to allow for comparison 
at the same time point between metabolic samples and protein expression of 
pHSL(SER563), western blot analysis would also be conducted on samples that had been 
incubated under basal and stimulated conditions for 120 min.  
As the parameters for cell treatment were now identified it was important to check that 
the compounds of interest would not interfere with the metabolic assay used to identify 
changes in adipocyte lipolysis.  Data in Fig. 3.15 and 3.16 illustrate that treatment with 
isoproterenol, acetate and insulin either alone or in combination would not interfere 
with the NEFA assay, regarding changes in background absorbance.  Similarly, samples 
collected after 120 min (Fig. 3.17), from cells incubated in the presence of 
isoproterenol, which were subsequently spiked with treatments including acetate and 
insulin, did not interfere with NEFA assay.  There is also literature on the potential 
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interference of buffers on total protein analysis (Mohan, 1997).  Compounds used 
within some lysis buffers e.g. Tris Buffers, have been identified as having the potential 
to interfere with the sensitivity of assays including the Bradford assay for total protein 
calculation.  This was also true for the 3T3-L1 lysis buffer as shown in Fig. 3.18 and 
Fig. 3.19.  However, it was identified that a 10-fold dilution of the recommended 1 x 
solution did not interfere with total protein calculation and so all subsequent samples 
containing the 1 x lysis buffer were diluted 10 fold before protein analysis.  
The effects of isolation of primary adipocytes on cell viability were also considered.  It 
was important to get a high yield of viable cells, but also ensure the least number of 
animals were used to obtain this.  There are a number of published protocols for the 
isolation of mature murine adipocytes (Rodbell, 1964, Hausman et al., 2008) however, 
the exact details associated with digestion buffers is limited.  As seen in Fig. 3.20, it 
was the DB containing both collagenase and liberase (DB3) that isolated the most viable 
cell population.  
Finally, consideration should also be given to the validity of other experiments which 
will not be covered in this thesis, but could also be of relevance.  Changes in NEFA and 
glycerol release are a reliable way of determining the effect of SCFA acetate availability 
on adipocyte lipolysis, but also experiments focusing on the activation of SCFA 
receptor GPR43 could also complement these data. The utilisation of known inhibitors 
of Gi linked receptors, such as pertussis toxin (Ge et al., 2008), would elucidate the 
involvement of GPR43 activation in the presence of supra-physiological concentrations 
of acetate. Similarly, while pHSL(SER563) will be analysed as a marker for intracellular 
changes to lipolysis, consideration of the analysis of total HSL and changes to pHSL(565) 
would also support the data acquired in this thesis, regarding a potential mechanism of 
action.     
Overall, from the analysis of initial experimental methods and from the hypotheses 
made, it can be concluded that all treatment compounds either individually or in 
combination do not interfere with the NEFA assay to any significant extent.  A 
concentration of 4 mM sodium acetate would be used in subsequent studies, as opposed 
to the hypothesised concentration of 2 mM, even though this would be considered 
supra-physiological.  This was due to the findings that 4 mM acetate was the lowest 
concentration tested to consistently inhibit NEFA concentration in the media over time, 
and therefore should be considered as a potential therapeutic target depending on the 
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results of the following studies.  As hypothesised, ~10 µM of the β-AR agonist 
isoproterenol stimulated the concentration of NEFA and glycerol in the media by 100 
%, however, as the relationship of the dose response was not linear, an exact EC50 could 
not be calculated. Also, from other data, it was clear that 10 µM isoproterenol masked 
the effects of 4 mM acetate and so a sub-maximal concentration of isoproterenol,   5 
µM, would be used in all subsequent experiments.  For western blot analysis, GAPDH 
was unaffected by treatment of isoproterenol as hypothesised and pHSL concentration 
increased in stimulated cells compared to the basal state.  Finally, all subsequent 
primary adipocyte isolation will be performed using DB3, as this combination produced 
cells with least cytotoxicity, and therefore most viable.  
 
 
 
 
 
 
 
 
 
 
 
 
 
56 
 
 
 
 
 
 
Chapter 4 
The effect of sodium acetate on white 
adipose cell basal lipolysis 
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Introduction 
As mentioned previously in Chapter 1, adipocyte lipolysis is the pathway responsible 
for the breakdown of intracellular TAG into glycerol and NEFA.  Regulation of this 
pathway involves the integration of many extracellular and intracellular signalling 
cascades, including SNS and insulin sensing to the cell surface, followed by lipolysis 
and lipogenesis within the cell itself.  To maintain homeostasis within the mature 
adipocyte, many substrates and hormones e.g. insulin, norepinephrine and cAMP, 
interact in a reciprocal way to either stimulate or inhibit lipolysis depending on the 
energy status of the cell.  These interactions occur simultaneously to ensure tight 
regulation of TAG availability. 
In the case of lipolysis, fatty acids hydrolysed from the glycerol backbone of TAG not 
only exit the cell into the surrounding plasma for use in other cells as an energy supply, 
but many become re-esterified back into TAG (Jensen et al., 2001).  However, under 
conditions including the post-prandial state, there is a sufficient supply of glucose to the 
cells and therefore the need for free-fatty acid production is reduced.  To ensure there is 
a reduction in NEFA release and increased uptake of available glucose, insulin acts via 
IR within the cell surface of adipocytes.  Insulin not only regulates uptake of glucose, 
initiating translocation of GLUT4 transporters from intracellular stores to the plasma 
membrane, but also inhibits lipolysis through the phosphatidylinositol 3’ kinase (PI3-
Kinase) dependent pathway and subsequent activation of PDE3B (Chaves et al., 2011, 
Cheatham et al., 1994).  Endogenous regulators such as insulin and norepinephrine are 
not the only influence on lipolysis, as there is evidence to suggest nutritional substrates 
also affect the metabolic function of lipolysis, including SCFA (Metz et al., 1974, Al-
Lahham et al., 2010, Ge et al., 2008, Taggart et al., 2005).  The three predominant 
SCFA include acetate, butyrate and propionate, which are found in the circulation after 
fermentation of fibrous foods in the gut by microflora, or metabolism of alcohol in the 
liver, and therefore effects on stimulated AT lipolysis have been noted previously 
(Nilsson and Belfrage, 1978, Bernalier-Donadille, 2010, Siler et al., 1999, Ferchaud-
Roucher et al., 2005). However, there is a reduced volume of literature on the effects of 
SCFA availability on basal lipolysis. 
Many metabolic studies conducted on the mature adipocyte cell line 3T3-L1 utilise 
endogenous or artificial stimulation of lipolysis e.g. epinephrine or isoproterenol (Daval 
et al., 2005, Hong et al., 2005, Mulder et al., 2005), however, it is understood that basal 
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lipolysis occurs in the absence of external stimulation.  A study by Nilsson and Belfrage 
(1978), demonstrated that in the basal state, glycerol release from isolated rat adipocytes 
was not significantly reduced in the presence of 10 mM acetate.  Furthermore, 
Morimoto et al. (1998) demonstrated a lack of insulin induced reduction in free fatty 
acid release from adipocytes isolated from non-fasted 8 and 10 week old rats.  In 
contrast, a study by Miyoshi et al. (2008) identified that stimulation of ATGL was 
important in basal lipolysis, as measured by a decrease in glycerol release in an ATGL 
knockdown models.  As the exact mechanism of action of acetate on adipocyte lipolysis 
is still unknown, it was hypothesised that in the presence of supra-physiological 
concentration of sodium acetate (4 mM), basal lipolysis would be not be decreased, in 
the form of NEFA and glycerol, and that there would be no additive effect in the 
presence of both insulin and sodium acetate.  
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Methods 
Briefly, on the day of sample collection, day 9 post differentiation, murine 3T3-L1 cells 
were washed in 37°C 1 x PBS before being placed in treatment media (DMEM plus 2 % 
bovine serum albumin – fatty acid free (BSA-FFA)).  Treatment conditions were 
prepared using 4 mM sodium acetate and 1.34 µM insulin, in the following 
combinations 1. Basal 2. Acetate 3. Insulin and 4. NaAc+Ins..  For sodium acetate 
treatments, cells were pre-incubated in the presence of 4 mM acetate for 30 minutes 
prior to PBS cell wash step.  Samples were collected every 60 minutes over a maximum 
period of 180 minute.  After the last sample was collected, cells were lysed and 
sonicated before being centrifuged at 10,000 x g for 10 minutes at 4°C.  Media samples 
were stored at -20°C and supernatants were stored at -80˚C.  NEFA, glycerol, TAG and 
total protein samples were analysed as described in Chapter 2.  Total NEFA and total 
glycerol (µmol/mg protein) were calculated using the area under the curve for each 
replicate from 0 to 180 min, before calculating the mean and standard error or median 
and quartiles for each treatment condition.  
 
Statistical analysis 
All statistical analysis was performed using IBM SPSS Statistics 20 software.  All data 
sets were checked for normality using the Shapiro-Wilk test as there were < 50 samples 
per data set, and a boxplot was used to check for outliers. Data found to be normally 
distributed were analysed using a 1-way ANOVA followed by post-hoc Tukey test.  
Paired non-parametric data were analysed using a Friedmans test followed by pair-wise 
Wilcoxin.  For un-paired data that were also non-parametric, data were analysed using 
Kruskal-Wallis followed by pair-wise Mann Whitney test.  A P value of ≤ 0.05 was 
considered statistically significant.  
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Results 
The effect of 4 mM sodium acetate and insulin on basal NEFA in the media from 
3T3-L1 cultured mature adipocytes 
Under basal treatment conditions NEFA increased from 0 to 180 min, with 0.005 
µmol/mg protein at 0 min, 0.089 µmol/mg protein at 60 min, 0.200 µmol/mg protein at 
120 min and 0.289 µmol/mg protein by 180 min.  In the presence of acetate, insulin and 
NaAc+Ins. there was no statistical change in NEFA compared with basal accumulation 
at time 0, 60 and 120 min.  However, at 180 min, in the presence of acetate, NEFA 
concentration in the media was significantly reduced compared with NEFA in the 
presence of basal treatment alone (P = 0.004).  
 
Fig. 4.1   4 mM sodium acetate reduced the concentration of NEFA in the media from 3T3-L1 
cells after 180 min incubation. Values are Median and Quartiles, *P = ≤ 0.05. n = 4 - 7. 
 
Total basal NEFA concentration over 180 minutes 
The total concentration of NEFA in the media in the presence of acetate alone (0.30 
µmol/mg protein) was not significantly reduced compared with basal treatment alone 
(0.43 µmol/mg protein), as shown in Fig. 4.2 (P = 0.462), as calculated by area under 
the curve.  In the presence of insulin and NaAc+Ins. treatments there was also no 
significant change in total NEFA compared with basal concentration alone (P = 0.530 
and P = 0.986, respectively).  
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Fig. 4.2   4 mM sodium acetate does not result in a significant decrease in total NEFA over 180 
min compared with total basal NEFA in the media.  The total concentration of NEFA is 
expressed as mean ± SE. n = 3 - 5. 
 
The effect of 4 mM sodium acetate and insulin on basal glycerol in the media from 
3T3-L1 cultured mature adipocytes 
There was no significant change in glycerol in the media when comparing basal 
treatment with acetate, insulin and NaAc+Ins at time 0 min (P = 0.387, P = 0.990 and P 
= 0.985) (Fig. 4.3).  The background concentration of glycerol at time 0 min in basal, 
acetate, insulin and NaAc+Ins. media was found to be, 0.43 µmol/mg protein, 0.55 
µmol/mg protein, 0.42 µmol/mg protein and 0.46 µmol/mg protein, respectively.  The 
concentration of glycerol in the media at 180 min had increased significantly compared 
with glycerol concentration at 0 min in basal (P = 0.000) and insulin (P = 0.002) treated 
cells, however, when comparing 0 min to 180 min glycerol concentration in the 
presence of acetate and NaAc+Ins., there was no significant change (P = 0.349 and P = 
0.340, respectively).  Within each time point, 0, 60, 120 and 180 min, there was also no 
significant difference in glycerol concentration when comparing basal treatment with 
acetate, insulin and NaAc+Ins (0 min P = 0.317; 60 min P = 0.279; 120 min P = 0.946 
and 180 min P = 0.210), see Fig. 4.3.  
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Fig. 4.3   4 mM sodium acetate did not alter glycerol in the media compared with basal 
treatment in 3T3-L1 cells during 180 min incubation.  Values are mean ± SE, *P ≤ 0.05. n = 2 - 
6. 
 
Total basal glycerol concentration over 180 minutes 
As shown in Fig. 4.4, there was no change in the total concentration of glycerol in any 
treatment condition compared with total basal glycerol alone (acetate P = 0.961; insulin 
P = 1.000 and NaAc+Ins. P = 0.999 vs. basal). 
 
Fig. 4.4   4 mM sodium acetate did results in a significant decrease in the total concentration of 
glycerol in the media  over 180 min compared with total basal glycerol.  The total concentration 
of glycerol is expressed as mean ± SE. n = 3 - 5. 
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Adjusted media glycerol concentration under basal lipolysis conditions in 3T3-L1 
cells 
Due to the high background level of glycerol present in the treatment media (Fig. 4.3), it 
was important to subtract this from each subsequent time point.  This allowed for 
identification of the true level of glycerol present in the media in each treatment 
condition over time.  As shown previously (Fig 4.3), there were no statistical 
differences in glycerol accumulation between acetate, insulin, NaAc+Ins and basal 
treatments at 0 min.  Therefore any differences in glycerol at subsequent time points 
(60, 120 and 180) could not be attributed to compound interference with the assay. 
Furthermore, after subtraction of time 0 min glycerol, as shown in Fig. 4.5, adjusted 
media glycerol concentration  after 60 min incubation had increased significantly in the 
presence of NaAc+Ins. compared with basal treatment (P = 0.039).  This significant 
change had been abolished by 120 min, as neither acetate, insulin nor NaAc+Ins. 
treatment resulted in a significant change in glycerol at this time point (acetate P = 
0.064, insulin P = 1.000 and NaAc+Ins. P = 1.000).  However, by 180 min, acetate has 
significantly reduced glycerol (0.127 µmol/mg protein) compared with basal treatment 
(0.374 µmol/mg protein) (P = 0.020).  Also, NaAc+Ins. had significantly reduced 
glycerol in the media by 180 min (0.140 µmol/mg protein), compared with basal 
treatment alone (P = 0.020).  
 
Fig. 4.5   In the presence of sodium acetate, adjusted glycerol concentration was reduced after 
180 min incubation.  Concentration of glycerol at 0 min was subtracted from each subsequent 
time point to calculate change in glycerol.  Values are means ± SE, *P<0.05 vs. basal. n = 2 - 6. 
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The effect of 4 mM sodium acetate and insulin on intracellular TAG in 3T3-L1 
cultured mature adipocytes under conditions of basal lipolysis 
There were no significant differences in intracellular TAG after 180 min incubation 
with each treatment (P = 0.719), as seen in Fig. 4.6.  Compared with basal treatment 
alone, incubation with acetate, insulin and NaAc+Ins. for 180 min, did not result in a 
significant reduction in intracellular TAG (P = 1.000, P = 0.745 and P = 0.999, 
respectively). 
 
Fig. 4.6   4 mM Sodium acetate did not result in a significant decrease in intracellular TAG after 
180 min incubation compared with intracellular TAG in basal treatment, mean ± SE. n = 3 - 6. 
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Discussion 
From the results of this study, it is possible to conclude that a supra-physiological 
concentration of sodium acetate does have a small inhibitory effect on the metabolic 
function of adipocytes, contrary to our original hypothesis.  This was evident through a 
reduction in both NEFA and glycerol media concentration after a 180 min incubation.  
However, total NEFA and total glycerol remained unchanged compared with control, in 
the presence of 4 mM acetate and 1.34 µM insulin.  Intracellular TAG levels also 
remained statistically unchanged in basal (un-stimulated) treatment conditions.  In 
agreement with the hypothesis, it would appear that at a concentration of 1.34 µM 
insulin was unable to reduce lipolysis, and therefore, there was no evidence for an 
additive effect in the presence of both sodium acetate and insulin at these 
concentrations.   
All treatment conditions were compared to basal concentrations of NEFA at 60 min 
intervals over the 180 min incubation.  In the presence of 4 mM acetate, the 
accumulation of NEFA in the media was significantly decreased after 180 min 
compared with basal treatment conditions.  .  However, as shown in Fig. 4.1, the only 
time point where the presence of acetate resulted in a significant reduction in NEFA 
media accumulation was in the final 60 min incubation. Furthermore, at a concentration 
of 1.34 µM, insulin did not reduce basal NEFA or glycerol at any time point over the 
180 min incubation.  Similar to these data, a study by Morimoto et al. (1998) 
demonstrated no change in FFA release in the presence of 10
-6 
M insulin. Furthermore, 
it should also be noted that the concentration of insulin used in this study would be 
described as physiologically high, as post-prandial concentrations of insulin reported by 
Poretsky (2010), only reach concentrations of around 350 pM.  There appeared to be a 
high background of glycerol present in the 0 min samples.  This may have been due to 
the composition of the treatment media, as although it was possible to control the level 
of background NEFA with BSA-FFA, we were unable to do the same for glycerol.  
Over 180 minutes there was a steady increase in the concentration  of glycerol into the 
surrounding media from treated cells, however, total glycerol (Fig. 4.4)  did not appear 
to vary significantly between treatments.  However acetate, insulin and NaAc+Ins. 
treatments did not significantly change total glycerol compared with basal conditions. 
Similarly, data reported in the study by Nilsson and Belfrage (1978) demonstrated 
minimal or no reduction in glycerol release in the presence of 10 mM acetate in the 
basal state.  Consideration should be given to the hypothesis that glycerol accumulation 
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in the media did not significantly alter over time due a lack of concentration gradient. 
With such a high background concentration of glycerol and supra-physiological 
concentrations of insulin in the media, it could be possible that hydrolysed glycerol after 
lipolysis could not exit the cell via aquaglyceroporins. (Carbrey et al., 2003) noted that 
AQP9, a common hepatic glycerol channel, expression was down-regulated in the 
presence of insulin compared with control. However, subtraction of the background 
concentration of glycerol from subsequent time point data in this thesis demonstrated 
significant changes in glycerol in the presence of each treatment.  In the presence of 
acetate, change in glycerol concentration decreased significantly at 180 min, however 
acetate had no effect at 60 and 120 min.  The change in glycerol concentration in the 
presence of insulin showed there was no significant reduction at either 60, 120 or 180 
min.  NaAc+Ins. treatment was most unusual as results showed a significant increase in 
glycerol concentration at 60 min; however a significant reduction by 180 min compared 
to basal treatment.  As the data from total NEFA and glycerol were not significantly 
different in the presence of all treatment conditions compared with the basal state, levels 
of intracellular TAG were also likely to remain unchanged.  At 180 minutes the data 
collected for intracellular TAG were as expected.  The small concentration of NEFA 
and glycerol d from the cells may account for a lack of significant change in total 
intracellular TAG.  However, it was noted during the protocol that the method for TAG 
isolation may introduce a certain level of human error.  This is due to the solidification 
of TAG during the centrifugation process occurring at 4ºC, and subsequent clumping of 
TAG on microtube walls.  Other methods of analysing TAG would be more relevant to 
this study, including organic extraction, or radiolabelling TAG for analysis before and 
after treatment. Also, one limitation identified from these data, is a lack of re-uptake 
data for both NEFA and glycerol, therefore it is only possible to draw conclusions on 
the accumulation of NEFA and glycerol in the media and not on actual release. This can 
be confirmed from the data, as it would appear in Fig. 4.1 that NEFA accumulation in 
the media went down between 120 and 180 min. This could be accounted for by a re-
uptake of NEFA into the cell for use either in mitochondria or as a substrate for 
lipogenesis. . 
Overall, it would appear that complementary to previously reported data, insulin does 
not significantly reduce free fatty acid accumulation in the media in the basal state, even 
at a supra-physiological concentration.  A concentration of 4 mM acetate was found to 
reduce glycerol and NEFA concentration after a 180 min incubation to a significant 
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degree.  However, when considering total NEFA, total glycerol and intracellular TAG, 
acetate was found to have no effect compared with basal treatment alone.    
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Chapter 5 
The effect of sodium acetate on white 
adipose cell stimulated lipolysis 
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Introduction 
Over the last 10 years there has been increased interest in the effect of nutritional 
substrates, such as SCFA, on the metabolic pathway of lipolysis in white adipose tissue 
(Ge et al., 2008, Hong et al., 2005).  As part of this, surface receptor activation and the 
lipolytic pathway, including glycerol and NEFA accumulation in the cell media have 
been reviewed in great detail (Lafontan and Langin, 2009, Duncan et al., 2007). 
Activation of the β-AR is an integral part in regulation of lipolysis in the presence of 
catecholamines and other peptide hormones i.e. norepinephrine, insulin and glucagon 
etc. (Mulder et al., 2005, Nakamura, 2006, Collins et al., 2004).  The β-ARs are located 
in the cell membrane of mature adipocytes, and the receptor found in highest abundance 
in adipose tissue is β3 (Collins and Surwit, 2001).  There can be either a stimulatory or 
inhibitory GPCR linked to the surface β-AR receptor (Rasmussen et al., 2011).  The 
binding of ligands to the surface receptor, and the coupling of a stimulatory G protein, 
initiates activation of adenylyl cyclase, increased availability of cAMP, subsequent 
PKA phosphorylation of HSL and perilipin and finally hydrolysis of stored TAG into 
diacylglycerol, monoacylglycerol, before releasing NEFA and glycerol (Ahmadian et 
al., 2009).  Under condition of inhibitory G protein coupling, Gαi, the initial adenylyl 
cyclase activation is blunted and therefore reduces the amount of available cAMP to 
promote TAG hydrolysis.  
There have been many β-ARs found within the plasma membrane of mature adipocytes, 
including the small human carboxylic acid receptor HM47A, prostaglandin receptors 
EP3 and PGE2 and the inhibitory G protein-coupled receptor GPR43, which has been 
identified as a receptor for SCFA (Ge et al., 2008, Le Poul et al., 2003).  Reasons for the 
presence of a specific receptor for SCFA within white adipose tissue have not been fully 
identified, but it does suggest that SCFA may play a part in regulation of adipocyte 
lipolysis.  A previous in vivo human study by Smith et al. (2007), observed that plasma 
concentrations of NEFA and glycerol did not rise after the consumption of sodium 
acetate.  The study aimed to identify the effects of acetate metabolism on fat and 
carbohydrate utilisation.  The authors administered either sodium acetate or sodium 
bicarbonate, both of which induced a metabolic alkalosis, where it was observed that 
both NEFA and glycerol concentration increased in the first hour after sodium 
bicarbonate ingestion but that sodium acetate ingestion did not result in a change in 
NEFA and glycerol, and there was a concomitant decrease in fat oxidation.  The authors 
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concluded that acetate did suppress lipolysis during a metabolic alkalosis, i.e. conditions 
that stimulated lipolysis (Smith et al., 2007).  As the changes observed in the study by 
Smith et al. (2007), were conducted in vivo, utilisation of the 3T3-L1 cell line would 
give more insight into the mechanism(s) of action of sodium acetate on stimulated 
adipocytes in vitro.  
Therefore, due to our understanding of GPR43 activation by SCFA, it has been 
hypothesised that incubation with 4 mM acetate will reduce β-AR stimulated 
phosphorylation of HSL at the serine 563 residue compared to control.  Furthermore, as 
it is widely documented in the literature that activation of the insulin receptor results in 
cAMP reduction to 5’AMP by PDE3B, we hypothesize that treatment of 3T3-L1 
adipocytes with 1.34 µM insulin in the stimulated state will also result in a decrease in 
pHSL(SER563).  As both inhibitory GPCR and insulin receptor activation have been found 
to reduce overall lipolysis, it is also hypothesised that NEFA and glycerol, and 
intracellular TAG will all be reduced compared with β-AR stimulation alone.  
.   
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Methods 
Briefly, on the day of sample collection, day 9 post differentiation, murine 3T3-L1 cells 
were washed in 37°C 1 x PBS before being placed in treatment media.  Treatment 
conditions were prepared using 5 µM isoproterenol, 4 mM sodium acetate and 1.34 µM 
insulin, in the following combinations 1. Isoproterenol 2. Iso+Acetate 3. Iso+Insulin and 
4. Iso+NaAc+Ins..  For sodium acetate treatments, cells were pre-incubated in the 
presence of 4 mM acetate for 30 minutes prior to PBS cell wash step.  Samples were 
collected every 60 minutes over a maximum period of 180 minute.  After the last 
sample was collected, cells were lysed and sonicated before being centrifuged at 10,000 
x g for 10 minutes at 4°C.  Media samples were stored at -20°C and supernatants were 
stored at -80˚C. NEFA, glycerol, TAG and total protein samples were analysed as 
described in Chapter 2.  
 
Statistical analysis 
All statistical analysis was performed using IBM SPSS Statistics 20 software.  All data 
sets were checked for normality using the Shapiro-Wilk test for data sets with < 50 
samples and with Kolmogorov-Smirnov test for data sets with > 50 samples, and 
boxplots were used to check for outliers.  Data found to be normally distributed were 
analysed using a 1-way ANOVA followed by post-hoc Tukey test.  Paired non-
parametric data were analysed using a Friedmans test followed by pair-wise Wilcoxin.  
For un-paired data that were also non-parametric, data were analysed using Kruskal-
Wallis followed by pair-wise Mann Whitney test.  A P value of ≤ 0.05 was considered 
statistically significant.  
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Results 
The effect of 4 mM sodium acetate on the phosphorylation of hormone sensitive 
lipase(SER563) in 3T3-L1 adipocytes 
In order to identify if sodium acetate and insulin were acting within the lipolytic 
cascade, changes in the phosphorylation of HSL(SER563) were analysed after a 120 min 
incubation.  In the presence of 5 µM isoproterenol, the relative volume of pHSL(Ser563) 
increased ~2.5 fold compared with the basal state of pHSL(Ser563), i.e. without 
stimulation (Fig. 5.1).  Incubating the cells with the addition of Iso+Acetate resulted in 
the relative volume of pHSL(Ser563) being reduced by 15 % compared with isoproterenol 
stimulation alone.  pHSL was also reduced in the presence of Iso+Insulin by 21 % and 
Iso+NaAc.+Ins. by 24 % compared with isoproterenol stimulation. 
 
Fig. 5.1   Sodium acetate and insulin resulted in a reduction in the phosphorylation of 
HSL(SER563) in the presence of isoproterenol.  Cell lysates were analysed by Western Blot and 
relative volume was calculated using ImageLab 3.0 normalised to GAPDH. n = 4. 
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The effect of 4 mM sodium acetate and insulin on the concentration of NEFA in 
the media from stimulated 3T3-L1 cultured mature adipocytes 
As shown in Fig. 5.2, in the presence of Iso+Acetate, the  concentration of NEFA was 
significantly reduced at both 60 min and 180 min (P = 0.004 and P = 0.02, respectively) 
compared with 5 µM isoproterenol treatment alone.  At 120 min however, Iso+acetate 
treatment did not reduce NEFA compared with isoproterenol treatment alone (P = 
0.078).  
 
Fig. 5.2   Sodium acetate resulted in a reduction in NEFA in the presence of isoproterenol at 60 
and 180 min.  Values are means ± SE, *P < 0.05 vs. isoproterenol. n = 3 - 8. 
 
Total stimulated NEFA concentration over 180 minutes  
Total NEFA concentration (µmol/mg protein) was calculated as the AUC of NEFA over 
180 minutes.  As expected, total NEFA concentration (See Fig. 5.3) followed the same 
pattern as seen in Fig. 5.2.  In the presence of Iso+Acetate there was a 42 % reduction in 
the accumulation of total NEFA in the media compared with 5 µM isoproterenol 
treatment alone (P = 0.025).  However, Iso+Insulin and Iso+NaAc+Ins. did not reduce 
total NEFA significantly (P = 0.142 and P = 0.101, respectively).  
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Fig. 5.3   Total stimulated NEFA concentration calculated over 180 minutes under each 
treatment condition.  Total NEFA was obtained by calculating the area under the curve for each 
replicate treatment condition. Values are mean ± SEM, 
*
P = 0.053, n = 3-5. 
 
The effect of 4 mM sodium acetate and insulin on the concentration of glycerol in 
the media from stimulated 3T3-L1 cultured mature adipocytes 
As shown in Fig. 5.4, in the presence of isoproterenol and Iso+Acetate treatments there 
was a steady and significant increase of glycerol in the media from 0 - 60 min (P = 
0.028 and P = 0.028, respectively), 60 - 120 min (P = 0.027 and P = 0.028, 
respectively) and 120 - 180 min (P = 0.028 and P = 0.028, respectively).  However, 
Iso+Insulin and Iso+NaAc+Ins. treatments did not result in a significant increase in 
glycerol at each time point over the 180 min incubation.  Unlike the NEFA results, there 
was no reduction in glycerol concentration in the presence of Iso+Acetate at any time 
point compared with 5 µM isoproterenol alone (0 min, P = 0.631; 60 min, P = 0.423; 
120 min, P = 0.749 and 180 min, P = 0.529).  This was also the case for Iso+Insulin and 
Iso+NaAc+Ins. treatments compared with isoproterenol alone, at time points 0 min (P = 
0.808); 60 min (P = 0.172); 120 min (P = 0.345) and 180 min (P = 0.139).  Due to the 
composition of the treatment media, it was difficult to eliminate all traces of glycerol at 
time 0 min, accounting for the high background level of glycerol at this time point. 
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Fig. 5.4   Sodium acetate does not results in a reduction in glycerol in the media in the presence 
of isoproterenol. Values are means ± SE, *P < 0.05 vs. isoproterenol. n = 3 - 6. 
 
Total stimulated glycerol concentration over 180 minutes  
Total glycerol was calculated using the area under the curve in the same way as total 
NEFA.  In the treatment conditions that contained insulin, both Iso+insulin and 
Iso+NaAc+Ins. did not significantly change the total glycerol concentration compared 
with 5 µM isoproterenol alone (Fig 5.5), (P = 0.302 and P = 0.439, respectively).  
Furthermore, treatment with Iso+Acetate did not result in a significant reduction in the 
total glycerol concentration compared with isoproterenol treatment alone (P = 0.262). 
Fig. 5.5   Total glycerol was not significantly reduced in the presence of acetate. Values are 
mean ± SE, n = 3 - 6. 
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Adjusted concentration of glycerol in the media in the presence of isoproterenol  
The effect of each treatment on the change in glycerol concentration (Fig. 5.6) did not 
follow the same pattern observed with NEFA (Fig. 5.2).  In the presence of each 
treatment there was no significant reduction in the change of glycerol concentration 
compared with 5 µM isoproterenol alone.  Although glycerol concentration appeared to 
increase at each time point it was only in the Iso+Acetate treatment where glycerol 
concentration was observed to increase between 60 to 120 min (P = 0.006) and from 
120 to 180 min (P = 0.013).  In neither the Iso+Insulin treatment nor Iso+NaAc+Ins., 
did we observe any change in glycerol concentration between 60 to 120 min.  However, 
during the final 60 min (120 -180 min) the glycerol concentration increased 
significantly in the presence of the Iso+Insulin (P = 0.053) and Iso+NaAc+Ins. (P = 
0.034) treatment.  
 
Fig. 5.6   Sodium acetate did not result in a reduction in glycerol in the presence of 
isoproterenol.  Concentration of glycerol at 0 min was subtracted from each subsequent time 
point to calculate change in glycerol concentration.  Values are means ± SE, *P ≤ 0.05, n = 3 - 
6. 
 
The effect of 4 mM sodium acetate and insulin on intracellular TAG in 3T3-L1 
cultured mature adipocytes under conditions of stimulated lipolysis  
Under conditions of stimulated lipolysis there was a slight decrease in the level of 
intracellular TAG (Fig. 5.7) compared with basal level (Fig. 4.6) as expected (300 
mg/mg protein vs. 523 mg/mg protein, respectively).  Iso+Acetate and Iso+Insulin did 
not result in a significant change in the level of intracellular TAG compared with 
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isoproterenol alone (P = 1.000 and P = 0.584, respectively).  There was also no 
significant change in the level of TAG in the presence of Iso+NaAc+Ins, (P = 0.274).  
Fig 5.7   Total intracellular TAG was not significantly changed under stimulated conditions in 
the presence of trearment compared to control. Values are mean ± SE, n = 3 - 6. 
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Discussion 
The aim of this study was to identify whether sodium acetate affects stimulated adipose 
tissue lipolysis in vitro.  These data demonstrate that as hypothesised, an increase in 
acetate availability (4 mM) can result in a reduction in the phosphorylation of HSL at 
the serine 563 residue and supports the significant reduction in NEFA concentration that 
was observed in the media.  Furthermore, as hypothesised, incubation for 120 min with 
1.34 µM insulin, reduced pHSL(SER563) by 21 % compared with isoproterenol stimulated 
cells alone. However, glycerol concentration did not significantly differ from controls. 
The process of lipolysis is undoubtedly complex with many factors influencing this 
pathway; these include activation of inhibitory/stimulatory G protein-coupled receptors, 
β-adrenergic stimulation, insulin/glucagon signalling and the interactions between these 
factors.  The regulation of lipolysis is therefore tightly controlled but also depends on 
the energy state of the cell, and the availability of substrates and hormones, e.g. glucose 
and insulin.  In this study we were able to identify an intracellular change to lipid 
metabolism, from the basal to stimulated state, through examination of the 
phosphorylation status of HSL.  Previously it has been shown that the phosphorylation 
status of HSL is critical in the catabolism of triacylglycerol.  Using both an in vitro 
model and intact cell model, Fredrikson et al. (1981) demonstrated that the 
phosphorylation of HSL was associated with the availability of cAMP and that the 
enzyme activity of HSL increased two-fold in the presence of the catalytic subunit of 
protein kinase and cAMP.  Under basal conditions of lipolysis, there was continuous 
low level phosphorylation of HSL(563).  Upon stimulation with the β-adrenergic receptor 
agonist isoproterenol, the level of phosphorylation increased 2.5-fold and this 
observation supports previous work showing an increase in pHSL in the presence of 
isoproterenol (Daval et al., 2005).  In this study we further demonstrated that the 
presence of sodium acetate reduced the phosphorylation of HSL by 15 % compared 
with isoproterenol stimulated cells alone.  To the best of our knowledge these novel 
findings demonstrate the ability of the SCFA, acetate, to decrease the level of 
phosphorylation at one of the key serine residues in HSL, at site SER563. A limitation 
of this study is however, the lack of data referring to the level of total HSL present in 
the presence of acetate treatment. This would provide a phosphorylation:non-
phosphorylation ratio as another form of analysis.  From the literature, it may also be of 
interest to investigate the effects of acetate on other phosphorylation site within HSL, 
including 659 and 660 (Anthonsen et al., 1998, Martin et al., 2009).  Also, the effects of 
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acetate on the phosphorylation of serine residue 565 may be of interest as 
phosphorylation of this site is linked to the inhibition of HSL activity (Garton and 
Yeaman, 1990), and hence it may increase in phosphorylation in the presence of acetate, 
in a reciprocal manner to the decrease in HSL(563) observed in this study. As HSL occurs 
below the converging step in lipolysis, linking insulin receptor activation and GPCR 
activation, it would also be of interest to investigate the importance of GPR43 
activation. Through the use of inhibitors of Gi coupled receptors, such as pertussis 
toxin, there would be more evidence for the hypothesis that acetate acts at the surface of 
adipocytes, and exerts its effects via a reduction in adenylate cyclase activation and 
therefore cAMP. Therefore, if considering the whole organism, it would also provide a 
novel therapeutic target for side effects of type II diabetes, including dyslipidaemia, as 
in this condition, insulin fails to reduce lipolysis, leading to an uncontrolled release of 
fatty acids and accumulation of low-density lipoprotein and very-low-density 
lipoprotein in the circulation (Garg and Grundy, 1990). If activation of GPR43 with 
supra-physiological concentrations of acetate could reduce lipolysis and hence NEFA 
release via an alternative pathway to insulin receptor activation, this may warrant 
further investigation.      
As mentioned above, the most common endogenous inhibitor of the lipolytic pathway is 
insulin and activation of the IR and insulin receptor substrate-1 (IRS-1) is known to 
interact with the lipolytic pathway in adipocytes, as reviewed in detail by Duncan et al. 
(2007).  It is well documented that under conditions of excess glucose availability, 
insulin not only increases glucose uptake through the GLUT4 transporter (Akiba et al., 
2004) but also stimulates the PI3-Kinase pathway (Choi et al., 2010, Letiges et al., 
2002).  The subsequent downstream signalling process is unresolved regarding the 
mechanism by which insulin decreases adipocyte lipolysis, however, protein kinase B 
(PKB) dependent (Berggreen et al., 2009) and independent pathways (Choi et al., 2010) 
have been proposed to operate.  Under conditions of high lipolytic stimulation, the 
phosphorylation of PKB on SER273 initiates the activation of phosphodiesterase 3B 
(PDE3B), which in turn hydrolyses cAMP into 5’-AMP (Omar et al., 2009).  This 
conversion to 5’-AMP results in a decrease in available cAMP and therefore reduces the 
ability of PKA to phosphorylate HSL and perilipin, both of which are essential for 
hydrolysis of stored triacylglycerol (Zierath et al., 1998).  Our results support these 
findings since in the presence of 1.34 µM insulin; there was an observed 21 % reduction 
in pHSL compared with isoproterenol stimulated pHSL alone (Fig. 5.1).  There was no 
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evidence for an additive effect in the presence of both acetate and insulin in the 
stimulated cells as pHSL(SER563) had only decreased by 24 % compared with 
isoproterenol stimulated cells. These data would suggest that both acetate and insulin 
are exerting their effect on the same pathway, and with a lack of an additive effect we 
can assume that at supra-physiological concentrations of both insulin and acetate, the 
pathway has reached saturation regarding the phosphorylation of HSL(SER563) .   
SCFA have an affinity to GPCR, with acetate exhibiting specific affinity for GPR43 (Le 
Poul et al., 2003).  Other studies have shown that activation of G protein-coupled 
receptors present in the cell membrane of adipocytes results in a reduction in the 
lipolytic rate as determined by the release of NEFA and/or glycerol (Koppo et al., 2012, 
Ge et al., 2008, Liu et al., 2009, Kong et al., 2011, Magnusson et al., 2010).  These data 
also agree with reports showing changes in lipolysis, expressed as a reduction in the 
level of glycerol and/or NEFA release, in the presence of ligands of GPCR containing a 
small carboxylic acid tail region (Zhang et al., 2005, Taggart et al., 2005) similar to that 
of sodium acetate.  However, the ratio between the NEFA and glycerol concentration 
was found to be lower than expected in this chapter.  It may, however, be that re-
esterification of fatty acids into the adipocyte and an increase in mitochondrial oxidation 
within adipocytes had taken place, which would account for the reduction in NEFA to 
glycerol ratio.  Also, as mentioned in Chapter 4, a lack of glycerol release in the media 
may also be accounted for by the large background concentration also found in the 
treatment media. Secondly, if re-esterification is taking place, glycerol may not be 
released from the cell as it would be required for re-esterification. As we did not label 
acetate or glycerol these suggestions are only speculation, and further experimentation 
would be required. Finally, there appeared to be no change in the level of intracellular 
TAG at the end of treatment incubation.  This unexpected result could be due to an error 
in the way the samples were extracted.  After the cells were lysed, intracellular TAG 
had solidified around the edge of the micro-tube and therefore it was extremely difficult 
to include all traces of TAG for assay.  In order to minimize error in future studies, 
methods such as organic extraction similar to that used by Miyoshi et al. (2008), and 
also solid phase extraction (SPE) as reviewed by Ruiz-Gutiérrez and Pérez-Camino 
(2000) should be considered. 
In conclusion, these data support the hypothesis that increased availability of the short 
chain fatty acid acetate reduces the level of phosphorylation of HSL(SER563) in mature 
3T3-L1 adipocytes to a level similar as that achieved in the presence of supra-
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physiological concentrations of insulin. However, it would be advantageous to also 
consider other phosphorylation sites, and the merit of measuring total HSL. However, 
the decrease in pHSL(SER563) is supported by the decrease in  NEFA media 
accumulation in the stimulated state. Glycerol accumulation in the media was not 
reduced to a significant extent under the same treatment conditions, however re-
esterification of fatty acids and the need for intracellular glycerol could account for this 
lack of accumulation in the media.  
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Introduction 
It has been identified in Chapters 4 and 5, using the 3T3-L1 cell line, that in the 
presence of 4 mM sodium acetate, both basal and adrenergic stimulated lipolysis is 
disrupted, as shown by changes in NEFA and glycerol accumulation in the media over 
time.  To expand on these findings, primary adipocytes were treated with acetate, 
insulin and NaAc+Ins. in both basal and adrenergic stimulated conditions.  The results 
obtained would identify if primary mouse adipocytes were also susceptible to change in 
the presence of 4 mM sodium acetate.  
Data from Chapter 4 showed that in the basal state of lipolysis in 3T3-L1 cells, acetate 
reduced both NEFA and glycerol after a 180 min incubation, but that these changes 
were not reflected in total NEFA and glycerol concentrations.  Furthermore, as 
hypothesised, insulin did not reduce NEFA or glycerol in the basal state. Finally, acetate 
treatment had no effect on intracellular TAG concentration.  Under β-AR stimulated 
treatment conditions in Chapter 5, however, acetate reduced total NEFA in the media 
from 3T3-L1 cells significantly.  Therefore, it would be expected that primary murine 
adipocytes would be affected similarly by the same treatments.  As shown by Berggreen 
et al. (2009), isolated rat adipocytes showed a ~ 3 fold increase in glycerol release in the 
presence of 100 nm isoproterenol compared with basal release, and that this was 
reduced by ~ 60 % in the presence of 1 nm insulin.  Similarly Ge et al. (2008) noted that 
glycerol release from primary adipocytes isolated from epididymal fat pads increased in 
the presence of isoproterenol and decreased in the presence of insulin. In the same 
study, Ge and colleagues (2008) demonstrated a reduction in glycerol release by ~ 50 % 
from isolated cells incubated in the presence of propionic acid and acetic acid.  These 
data were complementary to those observed from the 3T3-L1 cell line, under the same 
treatment conditions.  Therefore the potential effect 4 mM acetate may have on 
stimulated lipolysis in isolated adipocytes may reflect those observed in previous 
chapters.  However cell specific differences between cell line and primary cell 
adipocyte models (Berggreen et al., 2009), and depot specific differences within 
primary cell models have been observed (Caesar et al., 2010, Macotela et al., 2009).   
Commonly, adipose tissue can be isolated from the subcutaneous and visceral depots 
(Caesar et al., 2010) of humans and mammals for use in metabolic studies.  The 
presence of adipose tissue in locations including PG/ED and subcutaneous (SC) areas; 
have resulted in the identification of regional differences in adipose tissue metabolism 
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and function (Bolinder et al., 1983, Van Harmelen et al., 1998).  As shown in a study by 
Macotela et al. (2009), PG/ED adipose tissue excised from female C57BL6 mice, had 
increased insulin sensitivity compared with adipose tissue excised from the SC region 
of the same animals.  The sex of the animals used in experiments has also been found to 
change the metabolic response of adipose tissue to stimuli, as Macotela et al. (2009) 
demonstrated that both PG/ED and SC depots excised from C57BL6 female mice had 
increased insulin sensitivity compared with the same depots of C57BL6 male mice.  
Therefore, from information collected from the literature, and from the results obtained 
in chapters 4 and 5, it was hypothesised that mature adipocytes isolated from female 
C57BL6 mice may be highly sensitive to insulin in the stimulated state.  Similarly, as 4 
mM acetate reduced NEFA to a significant extent from 3T3-L1 cells, it was 
hypothesised that the same concentration of acetate would also inhibit NEFA and 
glycerol concentration in the media from treated mature murine adipocytes after a 180 
min incubation.   
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Methods 
All animal work was completed at the Roslin Institute, Edinburgh. An established home 
office licence for animal testing at the Roslin Institute covered the euthanasia process 
described for this study. All mice were euthanized by spinal dislocation by a trained 
member of staff with a personal home office licence. Fat pad isolation was also 
undertaken at the Roslin Institute, before isolated cells were transported back to Heriot-
Watt for analysis. No ethical approval was needed for this experiment at either institute. 
From the literature, female C57BL6 mice have demonstrated a higher rate of adipose 
tissue metabolism than males and that the PG/ED adipose tissue depot is more insulin 
sensitive than SC depots.  For this reason, the primary tissue used within this study was 
excised from female C57BL6 mice and isolated from the PG depot.  Briefly, 6 16-week 
old female C57BL6/J mice were sacrificed by spinal dislocation, before the PG/ED fat 
pads were excised.  Each set of fat pads were washed before being cut into small 2 - 4 
mm pieces and placed in DB for 45 minutes, shaking at 37°C.  Isolated mature 
adipocytes were then filtered and centrifuged for 10 min at 1100 rpm at room 
temperature.  Isolated cells were pooled from 6 mice and split between one full panel of 
treatments (basal, acetate, insulin, NaAc+Ins., isoproterenol, Iso+Acetate, Iso+Insulin 
and Iso+NaAc+Ins.) and washed a further 2 times in KRBHA for 1 minute at 500 rpm. 
After the final wash step, 150 µl packed cells were plated in 600 µl plating media in a 
12 well plate format.  Cells were then placed at 37ºC for 4 hrs to stabilize before the 
addition of the experimental treatments. All experiments were run in duplicate. 
 
Treatment 
Cells that were treated with sodium acetate were spiked with 4 mM sodium acetate 
exactly 30 minutes prior to the start of the treatment protocol.  Plating media was not 
aspirated at the start of the experiment, therefore at time 0, each well was spiked with a 
combination of stock (x100) solutions of isoproterenol (500 µM), acetate (400 mM) and 
insulin (134 µM) to give a final concentration of 5 µM isoproterenol, 4 mM sodium 
acetate and 1.34 µM insulin.  Samples were collected every 60 minutes over a 
maximum period of 180 minutes and stored on ice.  After the last sample was collected, 
cells were lysed, sonicated and centrifuged.  Media samples were stored at -20°C and 
cell supernatants were stored at -80˚C. Samples were analysed for NEFA, glycerol and 
total protein as described in Chapter 2. 
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Statistical analysis 
All statistical analysis was performed using IBM SPSS Statistics 20 software.  All data 
sets were checked for normality using the Shapiro-Wilk test as there were < 50 samples 
per data set, and a boxplot was used to check for outliers.  All data found to be normally 
distributed were analysed using either a 2-Way ANOVA with post-hoc Tukey test or a 
1-Way ANOVA with post-hoc Tukey test.  All paired non-parametric data were 
analysed with Friedmans, and independent non-parametric data was analysed using the 
Kruskal-Wallis with pair-wise Mann-Whitney.  A P value of ≤ 0.05 was considered 
statistically significant. 
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Results 
The effect of 4 mM sodium acetate and insulin on basal NEFA in the media from 
mature murine adipocytes 
As shown in Fig. 6.1, there were no significant changes in NEFA in the media in the 
presence of acetate, insulin or NaAc+Ins. compared with basal treatment at 0 min (P = 
0.578, P = 0.999 and P = 0.987 vs. basal, respectively); 60 min (P = 0.704, P = 0.997 
and P = 1.000 vs. basal, respectively); 120 min (P = 0.590, P = 0.970 and P = 0.985 vs. 
basal, respectively) or 180 min (P = 0.775, P = 0.992 and P = 1.000 vs. basal, 
respectively). NEFA concentration did not increase over time, as the concentration of 
NEFA in the media at time 0 min (basal 0.043 ± 0.007 µmol/mg protein; acetate 0.058 ± 
0.003 µmol/mg protein; insulin 0.045 ± 0.002 µmol/mg protein; NaAc+Ins. 0.046 ± 
0.014 µmol/mg protein) was not significantly different from the concentration of NEFA 
in the media at 180 min (basal 0.037 ± 0.005 µmol/mg protein; acetate 0.046 ± 0.004 
µmol/mg protein; insulin 0.040 ± 0.000 µmol/mg protein; NaAc+Ins. 0.036 ± 0.012 
µmol/mg protein) P = 0.397.  
 
Fig. 6.1   Acetate did not result in a significant change in NEFA at any time point over the 180 
min incubation compared with the basal state. Values are mean ± SE. n = 2. 
 
Total basal NEFA concentration over 180 minutes 
The total accumulation of NEFA in the media over the 180 min incubation did not 
change significantly between the 4 treatment groups (P = 0.771), as shown in Fig. 6.2.  
Compared with basal treatment alone, acetate, insulin and NaAc+Ins. treatment did not 
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results in a significant reduction in NEFA (P = 0.838, P = 0.999 and P = 0.998 vs. 
basal, respectively).  
 
Fig. 6.2   Total NEFA did not significantly change in the presence of acetate, insulin or 
NaAc+Ins. compared to basal treatment. The total concentration of NEFA in the media is 
expressed at mean ± SE. n = 2. 
 
The effect of 4 mM sodium acetate and insulin on basal glycerol in the media from 
mature murine adipocytes 
As shown in Fig. 6.3, in the basal state neither acetate, insulin or NaAc+Ins. resulted in 
a significant change in glycerol at 0 min (P = 0.359), 60 min (P = 0.563), 120 min (P = 
0.823) or 180 min (P = 0.710).  Similarly, there was no significant change in glycerol 
concentration between time points (0 – 60, P = 0.999; 60 – 120, P = 0.995 and 120 – 
180, P = 0.565).  When comparing glycerol concentrations it was also apparent that 
glycerol concentration in the media after all treatments at 180 min, was not significantly 
different than glycerol concentration at 0 min (P = 0.609).  
Fig. 6.3   In the basal state, the presence of acetate did not result in a significant change in 
glycerol over 180 min incubation. Values are mean ± SE. n = 1 - 2. 
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Total basal glycerol concentration over 180 minutes 
The total concentration of glycerol in the media in the basal state was 0.02 ± 0.01 
µmol/mg protein over the 180 min incubation, as shown in Fig. 6.4.  Total glycerol in 
the presence of acetate, insulin and NaAc+Ins. did not significantly differ from glycerol 
in the basal state (P = 1.000; P = 0.997 and P = 0.969 vs. basal, respectively).  
 
Fig. 6.4   Total glycerol in the presence of acetate did not significantly change compared to 
basal state.  The total concentration of glycerol in the media is expressed at mean ± SE. n = 2. 
 
The effect of 4 mM sodium acetate and insulin on stimulated NEFA in the media 
from mature murine adipocytes 
As shown in Fig. 6.5, in the presence of 5 µM isoproterenol, NEFA did not increase 
significantly between 0 min (0.044 ± 0.002 µmol/mg protein) and 180 min 0.042 ± 
0.002 (P = 0.981).  Also, treatment of primary mature adipocytes with Iso+Acetate did 
not result in a significant change in NEFA concentration in the media compared with 
isoproterenol alone at any time point over the 180 min incubation (0 min P = 0.896, 60 
min P = 0.823, 120 min P = 0.297 and 180 min P = 0.114).   A comparison of 
Iso+NaAc+Ins. with isoproterenol alone was conducted on NEFA over the 180 min 
incubation, and resulted in a significant change in NEFA concentration (P = 0.033).  
However, after further pairwise comparisons at each time point (0, 60, 120 and 180 
min), the effect of Iso+NaAc+Ins. was not statistically significant from isoproterenol 
alone (P = 0.711, P = 0.507, P = 0.421 and P = 0.090 vs. isoproterenol, respectively).  
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Fig. 6.5   In stimulated conditions, acetate did not result in a significant change in NEFA 
concentration compared to control.  Values are mean ± SE. n = 2.  
 
Total stimulated NEFA concentration over 180 minutes  
The total accumulation of NEFA in the media under stimulated conditions did not differ 
significantly between treatment groups (P = 0.343), as shown in Fig. 6.6.  Compared 
with isoproterenol alone, Iso+Acetate, Iso+Insulin and Iso+NaAc+Ins. did not result in 
a significant reduction in NEFA (P = 0.475, P = 0.421 and P = 0.372, respectively). 
 
Fig. 6.6   Total NEFA concentration in the media in β-AR stimulated conditions did not change 
significantly in the presence of acetate, insulin or NaAc+Ins. after a 180 min incubation. The 
total concentration of NEFA is expressed as mean ± SE. n = 2. 
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The effect of 4 mM sodium acetate and insulin on stimulated glycerol in the media 
from mature murine adipocytes 
As shown in Fig. 6.7, in the presence of β-AR stimulation, glycerol did not change 
significantly over the 180 min incubation period (P = 0.102).  Similarly, stimulated cells 
treated with Iso+Acetate, Iso+Insulin and Iso+NaAc+Ins. did not result in a change in 
glycerol over the 180 min incubation (P = 0.257, P = 0.414 and P = 0.157, 
respectively).  There was no effect of treatment conditions on glycerol concentration in 
the media compared with stimulated treatment alone.  As expected there was no 
significant difference between treatment conditions Iso+Acetate, Iso+Insulin and 
Iso+NaAc+Ins. at time 0 min vs. isoproterenol (P = 0.480, P = 1.000 and P = 1.000, 
respectively).  In addition, there was also no difference observed at 60 min (P = 0.221; 
P = 0.683 and P = 0.683), 120 min (P = 0.157, P = 0.317 and P = 0.480) or at 180 min 
(P = 1.000, P = 0.157 and P = 1.000). 
 
Fig. 6.7   Under β-AR stimulation, acetate did not result in a significant change in glycerol 
within the 180 min incubation.  Data expressed as median and quartiles. n = 1 - 2. 
 
Total stimulated glycerol concentration over 180 minutes 
Total concentration in the media of glycerol under isoproterenol stimulation over 180 
min (0.027 ± 0.003 µmol/mg protein) was not significantly different from total glycerol 
in the presence of Iso+Acetate 0.020 ± 0.002 µmol/mg protein; Iso+Insulin 0.026 ± 
0.008 µmol/mg protein and Iso+NaAc+Ins. 0.020 ± 001 µmol/mg protein, (P = 0.841, P 
= 0.999 and P = 0.810 respectively), as shown in Fig. 6.8.  
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Fig. 6.8   Total glycerol in the media under stimulated conditions was not significantly different 
in the presence of any treatment condition compared with control.  The total concentration of 
glycerol is expressed as mean ± SE. n = 2.  
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Discussion 
From data collected in this study, treatments containing acetate, insulin and NaAc+Ins. 
did not result in a change of NEFA and glycerol in either the basal or β-AR stimulated 
state.  There appeared to be no concentration change in NEFA under basal conditions 
and limited change in stimulated conditions compared with time 0 min.  Glycerol 
accumulation in the media over 180 min, and total glycerol in the media after a 180 min 
incubation was not significantly changed in the basal or stimulated state in the presence 
of 4 mM acetate.  Also, insulin did not significantly reduce NEFA or glycerol in the 
basal or stimulated state over the 180 min incubation, and total accumulation in the 
media in the presence of insulin was unaffected compared with controls.  
Primary white adipocyte cell isolation is complex in that it covers the isolation of 
mature adipocytes and/or the stromal vascular cell (SVC) fraction for pre-adipocyte 
differentiation (Fernyhough et al., 2004).  Differences in DB, filter size and culture 
media exist between these protocols (Fernyhough et al., 2004).  There is even evidence 
to suggest standard isolation protocols can result in physiological changes to cell 
function, including activation of inflammatory responses (Ruan et al., 2003).  The 
method chosen for these experiments utilised a combination of both typical adipocyte 
collagenase and liberase, which contained a blend of both collagenase type I and type II. 
When considering the reliability of primary cell experiments, the viability of the 
isolated cell population is very important.  Identification of DB3 in preliminary 
experiments (Fig. 3.20), was used as it had demonstrated a mix of both collagenase and 
liberase was most effective at isolating the most viable cells.  It was therefore surprising 
to find that over the course of the 180 incubation, NEFA concentration in the basal state 
remained negligible (Fig. 6.1).  In comparison with Taggart et al. (2005), who reported 
a release of 0.25µmol/hr NEFA in the presence of 1 µM isoproterenol, the data 
presented in Fig. 6.5 show the average concentration of NEFA to be 0.042 µmol/hr, a 
~6 fold decrease in concentration.  The background level of NEFA present in the media 
at 0 min was also ~ 2 fold higher than represented in the paper by Taggart et al. (2005), 
however this may be due to differences in protocol used in this thesis. Isolated cells 
were left to stabilize for 4 hrs prior to the start of the experiment.  Cell media was then 
spiked with stock treatments, leading to the high background concentrations of NEFA 
and glycerol present in the time 0 min samples.  Comparisons with the literature have 
shown data from Chapter 6 do not fit well with expected results, however, it is of 
interest to identify if these findings complement cell line data from Chapter 4 and 5.   
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In this study, the concentration of total NEFA accumulation in the media from primary 
murine white adipocytes (Fig. 6.2) was roughly 4 fold lower than that of 3T3-L1 cell in 
the presence of basal and NaAc+Ins. treatments (Fig 5.3).  Similarly, in the basal state, 
total NEFA in the media from mature primary white adipocytes treated with acetate for 
180 min was roughly 2.5 fold lower (Fig 6.2) than total NEFA accumulation in the 
media from acetate treated 3T3-L1 cells (Fig 5.3).  In addition, treatment with insulin in 
the basal state resulted in a 5-fold difference in total NEFA accumulation in the media 
from primary murine white adipocytes compared with 3T3-L1 cells (Fig 5.2 and Fig 
6.3, respectively).  As shown by Taggart et al. (2005), data collected on the isolated 
epididymal adipocytes of wild type C57BL6 mice, NEFA release increased significantly 
under β-AR stimulation with isoproterenol.  This increase in NEFA was absent from the 
data collected within this thesis, as shown by a lack of change in NEFA concentration 
between basal (Fig 6.1) and isoproterenol (Fig. 6.5) stimulated cells.  Similarly, when 
comparing total glycerol in the media from primary murine white adipocytes with 3T3-
L1 cell line under basal and stimulated treatments, the 3T3-L1 cell line resulted in a 100 
fold higher concentration in total glycerol after β-AR stimulation, whereas no change 
was observed from primary cells. Furthermore, in the stimulated state, there was no 
significant change between treatments in the primary murine white adipocyte study 
compared to isoproterenol treatment alone.  From the data, it can be concluded that the 
primary tissue glycerol concentration is below expected values, as compared with other 
primary glycerol release concentrations (Qiao et al., 2011).  
Due to the results observed in this chapter, cell viability may be questioned when 
comparing basal to stimulated primary cells.  Also, the effect of pooling adipocytes 
from 6 different animals may also be a limiting factor. As stated in the methods section, 
it was not possible to rule out the presence of other cells, such as macrophages, within 
the isolated adipocyte layer after washing and filtration steps. Consideration should 
therefore be given to possible effects from combining cells from more than one animal, 
however as this is only speculation, this would need to be investigated further. 
As shown in Fig. 6.4, total glycerol accumulation in the media in the basal state (0.02 ± 
0.01 µg/mg protein) was similar to the concentration of glycerol present in the 
isoproterenol stimulated cells, shown in Fig 6.8 (0.02 ± 0.01 µg/mg protein) after a 180 
min incubation.  Experiments using primary mouse adipocytes conducted by Qiao et al. 
(2011), illustrated that in wild type animals, serum glycerol increased from ~0.2 
µmol/mg tissue to ~1.8 µmol/mg tissue in the presence of the β3-Adrenergic receptor 
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agonist BRL37344.  This would lead us to believe that cells in the study described in 
Chapter 6 in both basal and stimulated cell groups were not viable. This could have 
been confirmed had a cytotoxicity assay been performed at the end of the experiment to 
address if cells were still metabolising normally.    
In conclusion, studies looking at the metabolic function of mature isolated adipocytes 
have shown that under β-AR stimulation, both NEFA and glycerol release increases 
over time compared to the basal state (Taggart et al., 2005, Qiao et al., 2011).  However, 
within Chapter 6, results have shown no such increase in either media NEFA or glycerol 
during a 180 min incubation.  Similarly, the presence of acetate and insulin treatments 
did not result is a similar decrease in NEFA and glycerol from primary mature white 
adipocytes compared with data presented in previous chapters on 3T3-L1 cell 
metabolism.  Cell cytotoxicity was not assessed using the resazurin technique on these 
cells, and the effect of combining cells from more than one animal were also not 
investigated, however, from data collected on NEFA concentration from both basal and 
stimulated cells, it would appear that for the duration of the 180 min incubation, isolated 
mature adipocytes were not metabolising as evidenced by a lack of NEFA and glycerol 
accumulation into the culture media.  
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Chapter 7 
General Discussion 
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Overview 
This thesis has aimed to explore the effects of increasing dietary available compounds, 
such as SCFA, to levels above that found naturally in the circulation,  on adipose tissue 
metabolism and function in vitro.  Previously, supra-physiological concentrations of 
compounds have been identified as having therapeutic properties, including, nicotinic 
acid/niacin as a treatment for cardiovascular disease, which exploits the activation of 
HM74A, but at higher levels than normally found in humans (Pike, 2005, Zhang et al., 
2005). Dietary intake of carbohydrates, alcohol consumption and level of oxidation 
within tissues all contribute to changes in the concentration of acetate available in 
plasma, however, it is concentrations above those found naturally which may provide 
evidence for a therapeutic target in the prevention of a side effect of type II diabetes, 
dyslipidaemia.   As described in previous chapters, endogenous levels of acetate rarely 
increase above 2 mM, however artificially increasing the level of acetate, and the 
subsequent reduction of pHSL and NEFA concentration shown in this thesis, that is of 
interest.  These results will be discussed in relation to GPCR and insulin signalling, 
regarding a potential mechanism of action within adipocytes.  The discussion will 
compare results from this thesis with published studies, to identify similarities and 
differences in the data, so that changes observed in 3T3-L1 adipocyte in the presence of 
increased SCFA can be better understood. 
 
Short chain fatty acid acetate availability 
Previous publications have shown that intake of certain food groups influence the gut 
microbiota, and in turn affect the production of certain dietary available compounds, 
including the appearance of SCFA (Karlsson et al., 2013), through intake of non-
digestible carbohydrates and metabolism of alcohol in the liver (Macfarlane and 
Macfarlane, 2003, Al-Lahham et al., 2010, Siler et al., 1999, Puupponen-Pimiä et al., 
2002).  Although measurement of exogenous concentrations of SCFA produced by gut 
fermentation were conducted (Macfarlane and Macfarlane, 2003), and methods for 
crossing the gut barrier were proposed (McNeil et al., 1978), measuring the level of 
endogenous concentrations of SCFA were not easily accessible as methods used to 
measure portal and hepatic SCFA concentrations were considered highly invasive.  
However, since the first measurement of portal blood SCFA by Peters et al. (1992), and 
subsequent in vivo human experiments, there are data to suggest, both propionate and 
butyrate are utilised for gut membrane health or metabolised quickly in the liver after 
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entering the circulation (Bloemen et al., 2009).  Furthermore, the concentration of 
acetate found in the circulation is much larger than that of propionate and butyrate (Siler 
et al., 1999).  Identification of increased acetate availability in vivo, has led to studies 
that show acetate to be oxidised within the brain (Volkow et al., 2013, Jiang et al., 
2013) and heart (Yamashita et al., 2001), as well as the presence of SCFA receptors 
(Sawzdargo et al., 1997) within adipose tissue (Ge et al., 2008), and also the large 
intestine and islets of mice (Leonard and Hakak, 2006).  Concentrations of between 1 - 
2 mM acetate have been observed in plasma after infusion of 350 mM acetate in human 
studies (Jiang et al., 2013) and in the hepatic vein after controlled ingestion of ethanol 
(Nuutinen et al., 1985).  As shown in Fig. 3.7, initial studies to identify the active 
concentration of acetate on adipocyte lipolysis demonstrated that a concentrations of 2 
mM was able to reduce NEFA in the media after 180 min incubation, but had no 
significant effect on glycerol.  A concentration of 4 mM was required to reduce NEFA 
accumulation in the media after 120 min incubation in day 9 post-differentiated 3T3-L1 
cells.  Sodium acetate appears to be selective for a G protein-coupled receptor GPR43 
(Ge et al., 2008).  There are also data to suggest artificially increased concentrations of 
acetate, are sufficient to reduce lipolysis in vivo (Smith et al., 2007).  Nilsson and 
Belfrage (1978) noted that primary isolated rat adipocytes exhibited a dose dependant 
reduction in glycerol release, by 10 %, in the presence of 2 mM acetate and by 25 - 70 
% in the presence of 10 mM acetate.  In Chapter 5, in the presence of 5 µM 
isoproterenol, 4 mM acetate reduced NEFA from day 9 post-differentiated 3T3-L1 cells 
by ~35 % after a 180 min incubation, compared to isoproterenol stimulated cells alone 
(Fig. 5.2).  Therefore, previous studies have identified a GPCR specific for SCFA 
within adipose tissue, and that the presence of SCFA can result in a reduction in release 
of the products of lipolysis, including NEFA and glycerol, comparable with data 
presented in this thesis.  However, questions remained regarding the intracellular 
mechanism(s) linking extracellular surface receptor activation with NEFA and glycerol 
release. Utilising techniques such as western blotting for markers of lipolysis, including 
HSL would be one way of addressing this issue.  
 
GPCR and insulin receptor activation as a regulator of adipocyte lipolysis 
The lipid stored within adipocyte droplets is in a state of constant turnover, regulated in 
part, by the activation of surface receptor agonists and hormone sensing, as reviewed by 
Fain and Garcĩa-Sáinz (1983), Carmen and Víctor (2006).  Both stimulatory and 
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inhibitory agonists act simultaneously to maintain the homeostatic balance of TAG 
hydrolysis and re-esterification.  In the basal state when cells are not predominantly 
activated by stimulatory compounds such as catecholamines, the concentration of 
NEFA and glycerol is lower than that observed in stimulated cells as expected (Table 
5.1 and Table 5.2, respectively).  Activation of the lipolytic pathway increases as a 
result of β-AR activation.  When glucose is in short supply and the body requires an 
increase in ATP availability for energy, an increase in lipid metabolism is required to 
hydrolyse free fatty acids for use in mitochondria.  This increase has been known to 
occur in response to fasting, acute stress (Weissman, 1990) and smoking (Andersson 
and Arner, 2001).  Signals can originate extracellularly from areas including the CNS, 
intestinal tract and pancreas (Lustig, 2008).  As shown in Fig. 3.5, the dose response 
relationship for isoproterenol on NEFA accumulation in the media was not linear. The 
concentration required to activate 100 % NEFA accumulation in the media was ~10 
µM, complementary to concentrations used in other studies (Greenberg et al., 
2001{Sztalryd, 2003 #200, Brasaemle et al., 2004)}. As the data suggest in Fig. 3.6, 4 
mM acetate was unable to exert any reduction in NEFA media accumulation, therefore a 
sub-maximal concentration of 5 µM was chosen..  Previously, Tavernier et al. (2005) 
reported an isoproterenol EC50 on glycerol release of 462 ± 146 nm in adipocytes 
isolated from wild type male rodents, with a 14 fold increase to 6246 ± 5572 nm in 
isolated adipocytes from β-AR knockdown animals (β1-/-/β2-/-/β3-/-).  However, as 
shown in Fig. 3.6 of this thesis, the concentration required to maximally stimulate 
accumulation of glycerol from mature 3T3-L1 cells was ~10 µM isoproterenol.  
Differences in the sensitivity of adipocytes to isoproterenol may have occurred due to 
the use of primary cell and cell line models, and also the volume of tissue used.  For this 
reason, an EC50 concentration of 5 µM isoproterenol was used throughout this thesis.  
Studies show a range of receptors present in the adipocyte cell membrane, each of 
which contributes to the complexity of regulating the lipolytic/lipogenic relationship 
(Castan et al., 1994, Hong et al., 2005, Ge et al., 2008, Zhang et al., 2005, Zierath et al., 
1998).  As discussed in Chapter 1, there are many surface receptors which are Gi 
protein-coupled, and are capable of lipolytic inhibition, including GPR43 and HM74A.  
Activation of the EP3 prostaglandin receptor by PGE2 has also been reported to result in 
inhibition of lipolysis in mature adipocytes (Castan et al., 1994, Jaworski et al., 2009).  
There are also multiple compounds that activate these receptors including niacin, ketone 
bodies and short chain fatty acids (Nilsson and Belfrage, 1978, Pike, 2005, Taggart et 
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al., 2005).  A similarity between the agonists that activate the GPCR Gi may warrant 
further investigation, as each receptor agonist contains a small carboxylic acid tail 
region (Chang et al., 1997).  Acetate is a two carbon molecule with a single carboxyl 
group, and this tail region is shared by endogenous and artificial agonists, including 
niacin for HM74A (Pike, 2005, Zhang et al., 2005) and PGE1 for EP3 receptors (Green 
and Johnson, 1991).  However, the most common endogenous lipolytic inhibitor insulin 
acts via the insulin receptors present on adipocyte cell surface.  The action of insulin to 
supress lipolysis (Zierath et al., 1998), is secondary to increasing glucose uptake via 
Glut4 transporters and increasing adipogenesis as reviewed by Wilcox (2005).  
Activation of the insulin pathway has been well documented in adipose tissue (Koppo et 
al., 2012, Duncan et al., 2007, Ariotti et al., 2012, Berggreen et al., 2009).  An increase 
in extracellular glucose availability not only results in an increase in the release of 
insulin from pancreatic β-cells, but also an increase in Glut4 translocation to plasma 
membrane of adipose tissue (Sano et al., 2011).  Insulin binds to the insulin receptors 
present in the cell membrane of adipocytes, resulting in a decrease in lipolysis.  
Although the mechanism of action has been disputed in recent years (Choi et al., 2010), 
there is a general consensus that the activation of PDE3B converts cAMP into 5’AMP, 
and eventually decreases TAG hydrolysis and therefore NEFA and glycerol release 
(Berggreen et al., 2009, Kitamura et al., 1999).  As described in Chapter 2, human 
recombinant insulin was used throughout these studies at a concentration of 1.34 µM.  
However, as shown in Fig. 4.1 and Fig. 4.3, and Fig. 5.2 and Fig 5.4; at no point did 
1.34 µM insulin alone result in a decrease in NEFA and/or glycerol accumulation in the 
media from mature 3T3-L1 cells.  The proposed concentration of insulin used in these 
studies would be regarded as high, as others have used a much lower concentration and 
still observed inhibition or reduction in lipolysis (Cheatham et al., 1994).  A study by 
Mulder et al. (2005) on insulin induced Glut4 transport used 0.001 - 1 µM insulin.  They 
identified that 2-deoxyglucose uptake in the presence of 1 µM insulin was reduced in 
the presence of the β-AR receptor agonist, epinephrine, compared with insulin alone.  
Bolinder et al. (1983) used a range of insulin from 1 - 1000 µU/ml to detect changes in 
glycerol release as a measure of lipolysis in different adipose depots.   They identified 
subcutaneous adipocytes were more sensitive to a change in insulin concentration than 
omental depots.  Data gathered from metabolic studies within this thesis have 
demonstrated that insulin at a concentration of 1.34 µM was unable to reduce NEFA 
and/or glycerol accumulation in the media.  However, when investigating HSL levels in 
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treated cells, under stimulated conditions, insulin alone reduced phosphorylation of 
HSLSER563 by 21 %.   Under post prandial conditions, in humans, insulin levels only 
reach a concentration of ~350 pM (Poretsky, 2010), a quarter less than used in this 
study, and so 1.35 µM would be considered supra-physiological. 
There is a number of alternative phosphorylation sites to SER563, including SER565, 
SER600, SER659 and SER660 (Anthonsen et al., 1998, Greenberg et al., 2001, Martin 
et al., 2009).  These sites may also be affected in the presence of increased acetate 
availability.  From Fig. 5.1, pHSLSER563 increased by 2.5 fold in the presence of 5 µM 
isoproterenol, compared to the basal state.  A study in 2001 showed that catecholamines 
not only stimulated β3-activation but also activated extracellular signal-regulated kinase 
(ERK), controlling a novel HSL phosphorylation site at SER600 to increase lipolysis 
(Greenberg et al., 2001).  The increase in pHSLSER563 observed in the presence of half 
maximal β-AR stimulation by isoproterenol, was reduced by 21 % in the presence of the 
endogenous lipolytic inhibitor insulin, compared with stimulated cells alone.  Also, in 
the stimulated state, it was shown that phosphorylation of HSLSER563 was reduced by 15 
% in the presence of 4 mM acetate compared to stimulated pHSL alone.  It would 
therefore be of interest to investigate the effect of increased acetate availability on the 
phosphorylation of HSLSER565, as it was identified that phosphorylation of SER565 
occurs under basal conditions, in the absence of lipolytic stimulation (Garton and 
Yeaman, 1990). Similarly, it was shown in a study by Martin et al. (2009), that 
phosphorylation of the HSLSER565 residue was inversely proportional to the 
phosphorylation of HSLSER563 (Greenberg et al., 2001).  Identification of the importance 
of SER659 and SER660 to the activation of HSL should also be considered, as 
Anthonsen et al. (1998) showed that mutation of both SER659 and SER660, completely 
abolished HSL activation in COS cells.  However, mutation of only one serine site did 
not result in the same level of reduced activation compared to the mutation of both 
SER659/660.  It is also of interest to mention the limitations of these studies. As 
mentioned in previous chapters, due to a lack of data on total HSL levels present in the 
stimulated state in the presence of 4 mM acetate, we cannot provide a 
phosphorylation:non-phosphorylation ratio, which would define the exact level of 
pHSL(SER563) inhibition. However, complementary to these data, it was also 
identified that NEFA in the basal and stimulated state was also reduced in media in the 
presence of 4 mM acetate, however unlike our original hypothesis, under stimulated 
conditions; glycerol was not affected, compared with controls. Again, a limitation of the 
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data presented in this thesis should be considered when referring to accumulation of 
NEFA and glycerol in the media, which cannot be confused with measures of absolute 
release. As re-uptake of NEFA and glycerol were not calculated, via labelling 
techniques, absolute release cannot be calculated. In support of this, evidence of re-
uptake is apparent in the basal state, where there is less accumulation of NEFA in the 
media after 180 min compared with accumulation at 120. Similarly, a lack of change in 
glycerol release over time, may suggest glycerol is being re-esterified with available 
fatty acids, which could include the test compound acetate. Although this cannot be 
determined from the data presented in this thesis, acetate is not accounted for in the 
NEFA assay as evidenced by a lack of NEFA at time 0 min, showing a specificity for 
LCFA and MCFA.   
 
Increased acetate availability on NEFA, glycerol and TAG concentrations 
Overall, it can be concluded from the data presented in the previous chapters (4 and 5), 
that excess sodium acetate availability has a small but significant inhibitory effect on 
both basal and stimulated lipolysis of white adipose 3T3-L1 cells.  The basal rate of 
lipolysis was reduced in the presence of 4 mM acetate as shown by a reduction in both 
NEFA and glycerol in the media after a 180 min incubation, however intracellular TAG 
concentration remained unchanged compared with controls.  Data published by Ge et al. 
(2008), demonstrated basal plasma FFA from C57BL6 mice was reduced in the 
presence of 500 mg/kg acetate in less than 30 min and that % glycerol release was also 
reduced in the presence of sodium acetate compared to vehicle.  However, calculation 
of total NEFA and total glycerol in the basal state, in the presence of acetate, insulin and 
NaAc+Ins., showed there to be no overall reduction compared to controls, similar to 
data published by Nilsson and Belfrage (1978) and Morimoto et al. (1998).  In the 
presence of β-AR stimulated lipolysis, acetate significantly reduced NEFA in the media; 
however, both glycerol and TAG concentration remained unchanged compared with 
controls.  Previously, Zhang et al. (2005) reported a reduction in forskolin-induced 
intracellular cAMP levels and decreased glycerol release after activation of GPCR 
HM74A with niacin, in 3T3-L1 cells. Smith et al. (2007) also demonstrated that 60 min 
after ingestion of a sodium acetate bolus, a plasma acetate concentration of ~1.3 mM 
could result in a decrease in plasma FFA by 19 % compared with time 0.  Similarly, as 
shown in Fig. 5.2, NEFA concentration in the media was reduced by 22 % compared 
with control in the presence of Iso+Acetate, after 60 min of incubation.  Therefore, data 
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presented in Chapter 5 complement data from published studies utilising SCFA and 
GPCR agonists regarding their effect on adipose tissue lipolysis.  However, as noted 
previously, in contrast to published data, total glycerol concentration measured in the 
presence of each treatment did not reduce compared to controls.  
Previously, studies have shown evidence of re-esterification of fatty acids within 
adipocytes, where NEFA is re-esterified into TAG for storage in lipid droplets 
(Rodrigues et al., 2013, Zimmermann et al., 2003).  It is therefore possible that acetate 
not only acts to decrease pHSLSER563, but may also increase NEFA re-esterification and 
lipogenesis.  Data presented in Fig. 5.2 and Fig. 5.4, show that after 180 min incubation, 
the ratio of glycerol to NEFA was not 3:1 as expected.  Instead, a ratio of 1.5:1 was 
observed in this study under stimulated conditions.   Complementary to these data, in 
the basal state, after 180 min incubation, there was a negative concentration of NEFA, 
where the concentration of NEFA in the media was lower at 180 min compared with 
120 min.  This would suggest that NEFA was taken back into the cell to be utilised.  
Unfortunately, the method of TAG analysis used in this study was not accurate enough 
to clarify if NEFA was oxidised within the cell or converted back into TAG within lipid 
droplets.  Other methods may have been more reliable for TAG analysis and NEFA 
incorporation (Miyoshi et al., 2008).  From data gathered within these studies, it would 
therefore be of interest to investigate if similar changes were observed in isolated 
primary mature adipocytes. 
The total NEFA in the media from primary murine white adipocytes in the basal state, 
was found to be 4 fold lower compared with that from the 3T3-L1 cell line in two 
treatment conditions, basal and NaAc+Ins.  Concentrations of total NEFA in the media 
from primary cells in the remaining treatment conditions, acetate and insulin, were ~2.5 
fold and ~5 fold lower, respectively compared with the 3T3-L1 cell line.  Similarly, this 
pattern was also shown in the stimulated studies as the difference in total NEFA 
accumulation in the media in all treatment conditions between cell line and isolated 
primary adipocyte cells was over 14 fold.  Total glycerol from the 3T3-L1 cell line was 
roughly 100 fold higher than concentrations of glycerol in the media over 180 min from 
the isolated primary white adipocytes, and in the case of Iso+NaAc+Ins., the difference 
had increased to over 200 fold.  From these studies it would appear that data collected 
from the 3T3-L1 cell line studies aligns with other published data (Taggart et al., 2005, 
Qiao et al., 2011), however, the concentration of both NEFA and glycerol in the media 
from isolated primary white adipocytes in both basal and stimulated state was not 
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similar to previously published data (Berggreen et al., 2009, Ge et al., 2008, Taggart et 
al., 2005).  Any number of reasons may account for the results obtained within Chapter 
6 including a problem with cell viability, or a low cell number in each treatment well. 
In order to minimise mature primary adipocytes cell trauma during isolation, a selection 
of tissue DB were used to confirm the best combination of collagenase for the tissue 
type, and the resulting effects these buffers had on tissue viability (Fig 3.20).  A 
combination of both adipocyte specific collagenase and liberase was chosen as the cells 
isolated under these conditions appeared to produce the greatest viability against cells 
isolated in either collagenase or liberase alone.  However, as reported in Chapter 6, even 
after isolation with the preferred DB, mature primary adipocytes did not react to 
lipolytic stimulation with 5 µM isoproterenol.  This would suggest that during isolation 
the cells may have been stressed, contributing to the lack of change in NEFA and 
glycerol in the media. It may also be the case that the volume of cells used in the 
experiments was too low to detect a change in NEFA and glycerol.  A packed cell 
volume of 150 µl isolated mature adipocytes pooled from the tissue of 6 x 16 week old 
female mice was placed in 600 µl culture media for sample collection.  However, 
Rodbell (1964) reported the use of pooled adipose tissue from 3 rats (160-210g), with 
an estimated weight of 50 - 60 mg epididymal adipose tissue.  Unfortunately, fat pads 
were not weighed in the experiments of this thesis, however, from a pilot study carried 
out 6 months prior to these studies, fat pads from the same age matched female mice 
were ~ 400 mg/fat pad, showing that tissue volume was not a limiting factor in these 
experiments.  A release of 0.25 µmol/hr NEFA reported by Taggart et al. (2005) was 
also much higher than that shown in the data in Chapter 6, however their study did not 
state the weight or method of normalisation of adipose tissue used per treatment in the 
study.  Finally, the method of sample collection may be considered for revision if this 
experiment were to be repeated.  The method of obtaining the correct treatment 
concentration by spiking the media instead of aspirating old media and replacing it 
could account for the lack of change in NEFA and glycerol.  Cells were left to stabilize 
for 4 hr prior to the start of treatment incubation; however, instead of changing to 
treatment media at time 0 min, media were spiked with isoproterenol, acetate and 
insulin.  As the cells were already releasing NEFA and glycerol into the media in the 
basal state during the 4 hr stabilization period, any accumulation in the media due to 
treatment conditions after time 0 may have been masked by the high concentration 
already present in the cell media.  This may account for a lack of response in the basal 
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state however NEFA and glycerol release in the presence of the lipolytic stimulator 
isoproterenol would be expected to increase.  A study has shown that there can be a 9 
fold increase in glycerol release in wild type primary murine cells in the stimulated state 
(10 µM isoproterenol) compared to basal state (Sztalryd et al., 2003), therefore, even 
with the lack of media change, we would still expect to see an increase in NEFA and/or 
glycerol concentration in the isoproterenol alone treated cells.  
 
Future studies 
From data gathered and analysed throughout this thesis, several conclusion regarding 
the availability of acetate, and its effect on adipose tissue metabolism and function have 
been presented.  It was evident in basal treatment conditions that NEFA in the media 
was reduced, and that the concentration of NEFA in the media at 180 min was lower 
than the concentration at 120 min (Fig. 4.1).  This may be explained by re-uptake of 
LCFA from the media into the 3T3-L1 cells to be used in the re-esterification of NEFA.  
This observation is compounded by a lack of change in glycerol concentration into the 
medium compared to control.  Data suggest that for the measurement of small changes 
in intracellular concentrations of TAG, the method used throughout these studies may 
not have had the required sensitivity.  After contact with the manufacturer it was 
apparent that the Triglyceride kit had not been tested on adipose cells previously and so 
the manufacturer’s instructions may not have been suitable for TAG analysis in lysed 
3T3-L1 cells.  Further searches of the literature show that an alternative method of 
organic extraction followed by colorimetric determination of TAG as described by 
Schwartz and Wolins (2007) (Ruiz-Gutiérrez and Pérez-Camino, 2000)may have been 
more relevant to the 3T3-L1 cell model, detecting micro molar concentration changes in 
TAG which would reflect small changes in the total release of NEFA and glycerol.  
Furthermore, if this technique had been employed, it may have been possible to identify 
whether increased acetate availability would have increased NEFA re-esterification in 
the basal and stimulated state, and hence lipogenesis.  Future studies should therefore 
include investigation of markers of lipogenesis, including PPARγ.  
In conclusion, for the first time to the best of our knowledge,  acetate has been found to 
reduce the level of pHSLSER563 in mature 3T3-L1 adipocytes.  Secondly, in agreement 
with other groups, we have shown a decrease in concentration of NEFA in the media in 
the presence of a SCFA, however no significant change in glycerol.  There is also data 
presented in this thesis to hypothesize a potential effect of increased acetate availability 
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on adipocyte re-esterification, as exemplified by the decrease in NEFA:glycerol ratio to 
1.5:1.  Although, further studies identifying the effect of sodium acetate on lipogenesis, 
through targets such a PPARγ would need to be investigated.  This thesis also provides 
evidence that a concentration of ~10 µM isoproterenol is required to stimulate β-AR 
receptors by 100 % in 3T3-L1 mature adipocytes.  Overall, the presence of increased 
acetate availability has been shown to have a small but significant effect on the lipolytic 
pathway in 3T3-L1 adipocytes via a reduction pHSL(SER563) activity and subsequent 
reduced NEFA concentration; however, these studies do not rule out a potential 
interaction between reduced lipolysis and lipogenesis regarding the mechanisms 
controlling the effect of SCFA on adipose tissue metabolism and function. Therefore, 
regarding physiological relevance to the whole organism, these data support further 
investigation of supra-physiological concentrations of acetate as a potential therapy in 
the treatment of dyslipidaemia, a common side-effect of type II diabetes. The lack of 
insulin sensitivity present in patients with type II diabetes, results in uninhibited 
activation of lipolysis and hence NEFA release (Bolinder et al., 1983, Choi et al., 2010, 
Berggreen et al., 2009). We have demonstrated via a lack of additive effect regarding 
pHSL that both acetate and insulin result in inhibition of the same pathway. The 
identification of GPR43 as a receptor for acetate, gives further merit to the therapeutic 
potential of increased acetate availability, by way of increasing the control of lipolysis 
via a separate receptor to IR, and ultimately reducing NEFA release. However, 
consideration to the limitations of these studies should also be considered. As 
mentioned previously, experiments with known inhibitors of GPR43 would confirm 
surface receptor activation by acetate and the downstream effect on pHSL. Similarly, 
the use of total HSL and other phosphorylation sites of HSL would be advantageous. 
This would give further support to the metabolic data in this study, which complement 
previously published data in the presence of increased SCFA availability.       
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